RELIEF FOUNDATION Cjimcal Sciences Centre uVerS1ty Hospital lltree Lower Lane Liverpool 19 7AL Established as a Charitable Incorporaled Organisalion on I rh March 2014 Originally Eslabli.Ih¢d under a Deed of Trust Daied 31Y March 1979 Annual Report and Accounts th For year ended 5 April 2026 Registered Charity No.1156227
CONTENTS Management and Committees Legal and Administrative information Report of the Trustees Pain Relief Foundation Aims and PoliGies Chronic Pain 10 Resgarch and the Institute 11to12 Rese8rch Accommodation 12 Man8gem8nÉ Strnclure & Govemanc8 13 Risk Management & 8ssessment Trustee Recruitment 14 Advisory Sub-committees 15 Grant Making & Policies 16 Public Benefit 17 Powers of Investment & Investment Policy 18 ReseN8S 19 Fundraising Regul8tor & our fundraising promise 20 Donation Policy 21to22 St8t8ment of Trustee Responsibilities 23 Clinical Section & Educ8tion 24to26 Research Reports 26to29 Auditorfs Report 30to32 statement of Financial Activities 33 Balance Sheet 34to35 Cash Flow Statement 35to36 Notes forming part of the Financial Statements 37to44 Detailed statement of Financial Activities 451046
PATROTrIS Dame Lorna EF Muirhead, DCVO, DBE, GStJ, FROG Mr. R. N. S. Bigland TRUSTEES Mr. D. Cain, FRSA, FIOD, MHSM, DipHSM, (Chairman) Professor Michelle Briggs PhD RGN Miss J Daley, LLB (Hons) Professor P. Eldridge, MA, Mchir, FRCS Mr. P. Fell, MA (Cant8b), FRSA (Deputy Chairman/treasurer) Professor Francis MGGlone BSC (Hons), PhD Dr. T Nash. MB, BS, Dobst RCOG, FRCA, FFPMRCA Mr. M. Sharma, MBBS, MD, FRCA, MS¢, FFPMRCA Ms G Thompson Msc Dip AHCS MIMI Dr. J. C. Wells, MB, ChB, LRCP, MRCS, LMGC, SRCA, SIPP Dr. J. R. Wiles, MBBS, FRCA, FFPMRCA (rgsigned 21/05r2026) CHARITY MANAGER DArs J William8 SCIENTIFIC SUB-COMMITTEE Dr U Allam, BS¢, MPHe, MRCP(UK)(London), PhD Dr Jamie Burgess, PhD Miss. A. Bradshaw ProfJ Campbell PhD Msc Bsc CSt8t CPhys FRCOT FRS8 Dr. hl. Goodson, FRCP, PhD Dr K Heron, MSG, PhD, DClinPsyGh Dr Selina Johnson, PhD DrA Marshall MB Ch8, Bsc, FRCP, PhD Dr Anne M8rshall PhD Professor Francis McGlone ESC (Hons), PhD MrH Neiland Miss. C. Staunton PhD (Chair) EDUCATION SUB-COMMrtTEE Ms Alison Bradshaw Dr R. J. BerwiGk MBBS FRCA FFPMRCA Dr M Gupta MBBS, FRCA, FFPMRCA Dr K M8tthews, Consultant Clinical Psychologist Dr K. Pushparaj MBBS, MD. FFPMRCA Dr. M. Sharma, MBBS, FRCA, MD, FFPMRCA, Msc ( Chair) Mr. John letlow Dr. J. C. Wells, MB, ChB, LMCC, FRCA
REGISTERED OFFICE Clinical Sciences Centre University Hospital Aintree Lower Lane Liverpool L9 7AL BAIYKERS H.S.B.C. p.l.c. 99 -101 Lord Street, Liverpool, Merseyside. L2 6PG AUDITOR BTMR Limited, Statutory Auditor Century Buildings 14 St Mary's Parsonage Manchester. M3 2DF SOLICITORS John Roberts, Abensons Solicitors 102 Allerton Road, Liverpool, Merseyside. L182DG INVESTMENT ADVISORS Rathbone Investment Management Ltd., Port of Liverpool Building, Pier Head, Liverpool, Merseyside. L3 1NW
TRUSTEES, REPORT 2026 l am dp.lighted lo take this DPPOrtunity as Chairman of the Pain Relief Foundation Charity to introduce to you our Annual Report for the year ended 5th April,2026. We as a Trustee Committee are proud to maintain our strong reputation as Academic leaders in the field of chronic pain research and to maintain support to a wide group of Pain Specialists, Clinicians in Hospltals and Primary Care, our patients and their families and Carers. During the past year our team has worked hard to fijrther strengthen our research portfolio wilh our Partners at Liverpool University and the Walton Centre NHS Trust. We recognise the support from Professor Pder Clegg prior to his recent retirement from the University. Ourwork with the Walton Centre continues to focus both on Academic collaboration and direct engagement in clinical activities. Having been the founder Chief Executive at the Trust It has always been the case that this relationship is based on sound and long-lasting professional Ilnks. Our activities extend to numerous research publications, grant applications, and conferenca activities both in Ihe UK 8nd in Europe. Both Professor Andreas Goebel and Dr Andy Marshall our dedicated Senior Research Fellows are leaders in the field of research and continue to be acknowledged by thelr peers in Chronic Pain Management I would wish as always to recognise the tremèndous work of our Charity Manager Julie Wlllams and her team in both managing our Charity, having a focus on ¢ommunSty 8ngagement and donations particularly legacy giving. Thé governance and stewardship of our Charity enable us to hav8 Compliance with all asp8Cts of Charity regulation. We have in the year maintained solid and regular CommunitIOnS via social medla and via our website. Please enjoy rèadlng our Annual Report and do nol he$it8te to contact us if you wlsh to discuss or assist in continued ambition to be at the forefront of chronic paln research Standlng Strong In the Fight Agaln8t Chronic Paln In Ihe face of ongoing e¢onomic hardshlp, the Pain Relief Foundation remains steadfast In its mission to combat chronic pain through innovative research and education for the medical communlty. With a clear focus on flexibility and financial responsibility, the Foundation has Implemented strategic measures to ensur8 Sustalnable operats'ons, allowing it lo contlnu8 delivering meaningful Impact even in uncertain limes. At the core of our mission 1$ e deep commltment to funding transformative researoh. W8 believe that scientific discov8ry is the most powerful path to effective Irealmenls and lasting relief for mllllons living with chronic pain. Even amid financlal pressures. we have priorilised research fundlng helping to drive breakthroughs and advance pioneering studies that offer real optimism for the future of pain management. But our work extends beyond financial support, the Pain Relief Foundation is dedleated to supporting the next generation of experts and slienglhening collaboratlon across disciplines. The organisation actively supports emerging researchers, healthcare professionals, and champion collaborative initiatives that accelerate progress. By fostering knowledge, we ensure that advancemenls in research translate into better care and improved outcomes for patlants. Chroni¢ pain persists as a widespread yet often invisible struggle. magnified by systemic healthcare challenges and economic strain. Yet, the Foundation remains resolute. We are oonvinced that sustsined investment in science and compassion is essenlial to alleviating suffering, reducing isolation, and transforming lives. As a charity, the Pain Relief Foundation relies entlrely on the generosity of irndividuals like you. Every donation fuels critical research and brings us closer to a world where no one must face the daily burden of chronlc pain alone. Your support doesn't just fund labs and studies it fiJels hope, drives discovery, and changes lives.
With determination, inclusiveness. and dedication we move forward with positivty- Together, we envision a future where people with chronic pain can thrive, living full, active, and empowered lives, unhindered by their condition. What is Chronlc Paln: Pain is a universal experiénce, a built-ln alam systèm that wams us of Injury or Illn8ss and drives us to seek care. But what happens when that alarm doesn't turn off, even after the body has healed, wh8n pain persists far beyond ils original purrKJse. It evolves into somethlng much more serlous- chronic pain. Chronic pain is geneTally defined as pain that lasts for more Ihan three months, a timeframe that goes well beyond the normal healing process for most injuries or medical conditions. Unlike acute pain, which serves as a helpful warning signal and gradually subsides with treatment, chronic pain lingers, often without resolution. It is not simply prolonged acute pain but a complex condition in its own right. In fact, many expèrts now view chronic pain as a disease of the nervous system, not just a symptom. Over time, the body's pgin signalling pathways can become overactlv8 or rewlred. causlng the brain and neTves to continue sending pain messages even when there's no ongoing lissue damage. This means a person can experien real, often severe pain without an obvious physi¢al cause. The origins of chronic pain ar8 diverse and not always Glear-cut. Common contributors include- Mèdlcal Condltlons: Diseases like arthritis, fibromyalgla, neuropathy, and chronic back disoiders are frequent ¢ulpiits. Injuriès: While most Inlurles heal fully, some-especially those involving nerve damage-¢an lead to long-term pain. Surgery: Ironlcally, whlle surgery 18 often meant to relieve pain, it can sometimes result in chronic pain, p8rticularly If nerves are aff8cted during the procedure. Nerve Damage: Condltions such as dlabetes or shlngles can damage perlpheral neNes, leadlng to lasting pain syndromes like diabetic neuropathy or post-herpetic neuralgia. Unknown Causes: For many people, no clear source of pain can be identifled, making diagnosls and treatm8nt especially challenglng. Beyond the physlcal symptoms, chronlc pain takés a toll on mental health, sleep, relationshlps, and overall quality of Ilfe. It's not somethlng you can simply "push through It Is a perslstent, often Invlslble condition that requiras compasslon, compr6henslv• care, and a multldisaplinary approach. Chronic pain 18 more than jLSSt a bad day it Is a dally rèality for mlllions. Undèrstanding11 as a complex, mullifac@ted condition is the first step toward efflIve management and improved well-being. The Rlpplè Effect of Chronlc Paln: Living with chronic paln Is kind of Ilke havlng an unlnvited houseguest who never leaves, It Is more than just aches and pains,. it can quietly sneak into all area5 of life. Dally tasks might take a little longer and once easy activities like walking, dancing, or even folding laundry can start to feel like Olympic events and sornètimes you havè got to bow out last minute from that social event, which is hard for you and your friends. Emotionally, it can be a rollercoaster with anxiety and low moods, sleep might play hard to get, and lel's not forget the financial sidè you can f8el it In your wallét thanks to doctor visits, tr8atmenls. and maybe cutting back on work. But even with all this, people with chronic pain are often incredibly resilient, creative problem-solvers, masters of pacing. and pros at finding joy in small moments. It's a journey. no doubt but not withoul moments of connection, and quiet triumph.
Finding Llght in the Journgy: Managlng Chronic Pain with Hope & Help Living with chronic pain is no walk in the pad(, but there is the good news.. you're not alone, and there's a whole toolbox of help waiting for you. The key is finding what works best for your unique situation. and often that means mixlng and matching a few different approaches. Medications like pain relievers, certain antidepressants, or even antl-S8izure drugs can sometimes take the edge off and help you feel more like yourself. Bul popping pills isn't the whole story you also need movement. Gentle exercises, physical therapy, and stretching can do wonders for boosting strength, flexibility. and overall feel-good vibes. Your brain is also p8rt of your management. Cognitive Behavloural Therapy (CBT) helps reframe the way you relate to pain, giving you smart coping strategies and a mental edge. And don't forget the f6&1- good stuff: acupuncture, massage, or a mellow yoga class might be just what your body is craving. Some people even find relief through target8d treatrnents like netve blocks or injections, precision tools for stubborn pain spots. Relief is posslble, progress is real, and with the rlght rnix of support, you can find more comfort and more joy every day. Llvlng Well wlth Chronlc Paln Living with chronic pain, yes. it's dlfficult but that doesn't mean life has to be all gloom and doom. With the rlght support, a few smart strategies, and a small attllude adjustment, you can still enjoy the things you love 8nd mayb8 even discover some new on8s along the way. Think of It as working with your body instead of against it f5ndlng what helps, lettlng go of what doesn't, and celebrating the small wins. Whether it's leaning on your healthcare team, trying gentle movernent, or simply givlng yourself permisslon to rest guilt-free, every step counls. Millions around th8 world Ilvlng wlth chronic pain know lust how tough il ¢an be when even the Ilttle thlngs feel like a big deal, but the Pain Reliaf Foundation are on a mission to change that. At the Pain Relief Found8tion 8nd the Pain Research Institute, we are all about hope, help, and healing. We beli8ve a future with185s pain and more life is possible and we are d8t8rmined to make it happen. Together, we are building a world where chronlc pain doesn't dictate your life. By backlng brilliant science and Ihe passionate researchers we are investing in cutting-edge studies that don't lust manage pain bul alm to Iransfom how it is treated, with real people at the heart of every discovery. Thlnk of it as research that listens, cares, and reaches for breakthroughs that truly make a differen. But great research needs great understanding. That's why wo're lust as excited about education as we are about experiments because when people understand pain better, they can face It head on and with more support. Together, we can crack one discovery and conversation at a time. Finding better ways to relieve pain has never been more important. Mlllions of people are living with chronic pain, and It's time we tackled thls challenge with fresh ideas and even bigger collaboration. The Pain Relief Foundation and the Pain Research Institute are all about bringing people together doctors, scientists, therapists, and advocates to shar8 knowledge, spark innovation, and make real change happen. We're reaching out to healthcare professionals across the UK and around Ihe world, giving them the training they need to provide top-notch care. We are also building on groundbreaking research and making surè the voices of people with chronic pain are heard. Together, we are advancing through each breakthrough one day at a time. At the Pain Relief Foundation, we believe fighting chronic pain isn't just about science and care it is also aboul doing the right thing with every pound we receive. Our work is only made possible by kind- hearted donors like you, and we take that generosity seriously. We are all about responsible
fundraising and keeping things transparent, honest, and donor friendly, no pushy tactics. Just a heartrelt'thank you. and a Glear picture of how your support helps make life better for people living with chronic pain. hen you give to us, you wlll always know exa¢Uy where your money is going because you deserve to se8 the reg1, positive impact of your kindness This commitment goes w811 beyond just asking for support. At the Foundation, we believe in making every pound count that is why we keep a Careful eye on our spending, making sure every expense truly supports our misslon of h8lping people living with chronic pain. And when it comes to investing, we focus on sustainable growth so we can keep making a difference, year after year. Transparency is al Ihe heart of everything we do, here at the Foundation we keep our financial rerdS open and easy lo access. We regularly share financlal updates so donors and the public can see exact how funds are being used. Plus, we welcome outside auditors who double-check our work to make sure everything is accurate and sustainable. Thls commitment to openness is our way of saying and showlng how seriously wg take our responsibility as stewards of your support. Th8 Pain Relief Foundation know5 it couldn't do what il does without the amazing generosity of ils donors. With your continued kindness and commitment, we're able to make real strides in pain relief research. A huge, heartfelt thank you for supportlng us, every contribulion big or small brings hope to those in need. In short, th8 Foundation is steadfast in Its dedication to belng a responsible and accountable orgenisation, driven by ethical fundralslng practlces and prudent financlal management. 8y a(Jhering to these corè princlp18s. we ensure that our r8sources are utilised effectively to advance ils mission of alleviating human chronic pain. We remaln committed to upholding th8se standards, building trust, and Inspiring continued support for our crucial work in improvlng the lives of Ih08e suffering from chroni pain. This work is made posslble thanks to our Board of Trustees, each of them volunteers their lime, energy, and expertise to help gulde the Foundatlon. They play a key role in shaping our strategy and keeping finances on track, and we're truly grateful for their ongoing support and dedication. One of our blggest strengths is the dlversity of our Board. Wè'r8 lucky to have people from all kinds of backgrounds and industries, each bringlng thelr own unique insights and experienc8 to help us move fomard. Thls includes: Medlcal Profesglonals: ProvSdlng Invaluable expertlse In pain management and research, ensuring our 5nltlalives are grounded in the latest scientific advancements and best practices. Admlnlstratlve Experts: Guiding our operational efficiency and ensuring resources are allocated effectively to achleve our strateglc goals. Legal Professlonals: Ensuring compliance and providing guidance on ethical considerations, safeguarding the integrity of our operallons. Business Leaders: Bringing strategi¢ business acumen to the table, hèlping us develop sustainable funding models and MaMise the impact of our programs. Working together, the Board provides comprehensive oversight to ensure that every decision is dellberate and focused on achieving tanglble results. The Trustees malntain a rigorous system of continual review across both scientific and administrative operations. Given the current economic climate, our reserves are critical., consequently, we actively monltor our Reserves Policy to optimise resource allocation, maximise ifnpact, and ensure we ulilise our asgets to their fullest potential. A key compon8nt of our financial strategy Is the Investment Policy that govems the management of our reserwes. The Trustees actively collaborate with the Investment Management team at Rathbones, regularly reviewing and refining the Investment Policy to a¢hieve optimal perforniance while adhering to ethical and responsible investment principles.
Beyond financial considerations, we recognise the critical importance of risk management. Our Risk Assessment Policy is under constant scrutiny, ensuring that we proactively idenlify, understand. and mitigate potentsal risks to the charity. We are committed to implementing procedural changes as needed. This proactive approach allows us to protect our assets, safeguard our operations. and maintain the trust of our stakeholders. This commitment lo diligence and stewardship is the cornerstone of our sustainability, allowing us to build a lasting legacy of support for the Causes that matter most. Every year, our Trustees set the budget for our research grants. Once that's finalised. we open our call for applications. We make sure to spread the word through specialist journals, our website, ResearchResear¢h.¢om, and University and NHS bulletin$ to reach the best researchers WDrking in chronic pain. Once applications are received, they undargo a thorough initial assessment by our dedicated Scientlflc Advisory Sub-committee. Chaired by Dr. Caroline Staunton, thls sul>committee plays a pivotal role in ltte entire giant allocation process. Dr. Staunton and her team are entrusted with the vltal task of overseeing our research work, meticulously analysing the significant volume of scientific information submitted by applicants. The Scientific Advisory SUCoMMIttee provides InvaSuable guidance to th8 Trustses,. in identifying the most deserving applications for research grants, their expertise is essential in priorilising projects with the highest potenlial impact. Th8 sub-committee ensures that each application undergoes rigorou$ peer review of other re8earchers in th8 fièld to critically evaluate Ihe scientific merit, f6asibi1Sty, and potsntial impact of each proposal. This process guarantees that only Ihe rnost deserving projects are considered for funding. We are profoundly gratgful for the extensive work carried out by the Scientific Advisory Sub-committee throughout this lengthy and demanding process. Th81r expertise, commitment lo rigorous evaluation, and dedication to advancing chronic paln research are invaluable to Ihe Foundation. Through their efforts, we are confident that we are funding the most promislng research and ultimately contributing to a better quality of life for those living with chronic pain. A sel8Ctlon of reSeah reports from grants awarded by the Pain Relief Foundation c8n be found on our w8bsite www. ainrelieffoundation.o .uk. Just as importantly, wè're dèdicated to sharing thé latèst knowledge and technlques with healthcare professlonals, helping them provide the very best care for their patients. Our research and educational Initiatlves benefit greatly from Ihe support of the Walton Centre NHS Foundatlon Trust and its Pain Clinic. We are proud lo work alongside one of Europe's leading pain centres, whose dedication to patient care and innovation is second to none. We owe a speclal debt of gratitude to the Walton Centre's patients. By volunteering their time for our trials. théy play a vital, active role In helping us develop more effective ways to manage and treat pain. We extend our gratitude to the patients who generously volunteer for research projects at the Walton Centre and our partner institutions. Their participation in clinical trials reflects an inspiring commitment to advancing medical science, fueled by the hope of securing a brighter future for everyon6 livlng with chronic pain. The Pain Relief Foundation is making significant strides In advancing the knoSdg8 and skills of he8lthcare professionals in the treatment and management of Chronic pain. Driven by the dedicated "EducAlion Sub Committee., chaired by Dr. Manohar Sharma, the Foundation has successfulSy broadened its educational activities and increased the avallabillty of high-quality courses throughout the year. Building on the success of recent conferences, the Foundation continues to its reputation for providing high-calibre educational opportunities. The Education Sub-committee remains dèdicated to curating and delivering ex*ptional programming. Their efforts are bolstered by the committed support of committee members who actively oversee course development. Through this commitment to accessible, high-quality training. the Foundation continues to empower healthcare professionals lo provide more effective and compassionate patient care.
In August 2025 we facilitated the Leed5 Cadaver Workshop and InteentIOnal workshop for pain medicine Consultants and doctors in training to develop and update Iheir intervention skills. In June w8 facilitated the North England Pain Group (NEPG) meeting which was attended by pain specialists from all overthe north of England. Underthe organisation of Dr Hemkumar Pusharaj and Dr Manoharsharma we ran our annual workshop Cllnlcal Management of Chronlc Paln Course, a practical approach to pain medicine. Planning is also underway for the biannual European Pain Federation EFIC Llverpool Winter Cancer Pain School due to be held in October 2026 Other workshops are currently being drafted to run throughout the year. Dr Chris Wells was r8sponsible for organising this yearfs Annual Lecture and Dr Manohar Sharma was sponsible for the Sludent Essay competition. The student essay competition was again opened to Medical, Nursing. Occupational Therapists, Psychology and Physiotherapy students. With the winners of each category presenting Iheir essay at one of our educational meetings. The work of the Foundation is a collaborative endeavour, including volunteers, staff, and external partners. This report serves as an opportunity to shine a light on these individuals and Tecognise tle integral role they play. First and foremost. we extend our heartfelt gratitude lo our volunteers. Their selfless donation of time and energy is invaluable. Vvilhout Iheir dedication, we simply wouldn't be able to impact as many lives as we do. Our deepest gratllude also goes to our Charity Manager, Julie Williams, and her dedicated team.. Hayley Mccullough, and Jo Stephens. They are the driving forcè behlnd ovr dally operations. working consoentiously throughout the year to ensure the $rnooth and effectlve execullon of our projects. Financial integrity and transparency are paramount. and we are fortunate to have the expertlse of Kath Johns and Emma Shepherd of BTMR Ltd, our Statutory Audllors. Thelr mellculous preparatlon and auditing of our accounts guarantee a¢counlabllity and allow us lo maintain the trust of our donors and beneficlarS@s. We appreciate thelr diligent work and commitment to upholding the high8St standards. Flnally, we extend our thanks to Joseph McLoughlin & Ethard Kenny of Rathbones Investments. Their expertise in managing our investment portfolio Is cruclal to ensuring the long-term financial stabllity of the Foundation, allowing us to continue supporting our pmgrams and fvlfllllng our m5sslon for year8 10 come. The success of our foundation is a testament to the dedication and hard work of these indlviduals. Alms The aims and objects of the Paln Relief Foundation, as set out in the Conslitution, are thè advancement and promotion of all forms of medical research and in particular the relief of human pain and all painful conditions of every type whatsoever and howsoever caused and to diswrinate Ihe results of any such research throughout th8 world. Pollcies to further Alms & Ob octlves In PuFsUan of these alms and objectives, the continued policy of the Trustees is lo..
Fund and enable Search Into the causes and optimal treatmerst of human chronic pain. Provide and maintain a Pain Research In8ti1ute, headed by a Professor of Pain Scienc6. in which research and education is conducted in pursuance of the charity's objectives. Undertake the support of the Pain Research Institute as a priority in the Pain Relief Foundation's funding programme. However, research grants wlll also be made availablè and awarded by open competition, for qualitative research projects carried out in other institutions. Support partnerships with higher education and the N.H.S directed to the understanding and treatment of human chronic pain. In particular, lo provide long-term fijnds for the support of a Chair in Pain Science at the University of Liverpool.
Support the dissemination of the results of such research throughout the world. Promote and enable education and training for doctors and other health. professionals on human chroni¢ pain and its trealmenls. Provide doctors and other health professionals with an information servic8 on chronic pain and ils treatments, in order to improve patient care. Provide an information service to hurnan chronic pain sufferers and patients on chronic pain conditions. This policy has remained unchanged since the last annual report. Chronic Pain Statistics Millions of adults are livlng with 'Great Pain Shame,. A study found that those with an ailment that affects their day-to-day existence rarely tell others about the pain they're in. "The prevalènce of pain is huge. It dwarfs m08t other conditions. PAIN AFFECTS US ALL The Departrnent of Health reco9nlses chronlc pain both as a long-term conditlon in ils own rlght and as a component of other long-term conditions. Across the UK there are currently 14 million peopl8 living w5th chroni¢ pain. HEALTH AND SOCIAL CARE 661/0 of people att8ndlng A & E sooklng help wilh pain had mad8 3 vlsits to a health care professional in tho preceding weeks. 160/0 of ¢hroni¢ pain patlents feel that their chronic paln Is so bad that they sometlmes want to dle. WELFARE AND BENEFITS Of the 14 milllon people living with chronic paln. 3.5 mllllon said their pain had kept thern from their USLJal aclivilies, including work, on at least 14 days in the last 3 months. EMPLOYMENT The CMO report slates that 250/0 of chronlc pain patients lose thelr jobs, this contrlbutes to 42Q/o in th6 lowest income households beSng more likely lo report chronic pain. compared with 270 in the highest. 410/0 of people who attended pain clinics report that their pain has prevented Ihern from working and 13 % have had to reduce their hours. SOCIETAL IMPACT Low back pain is ranked highest out of 291 conditions ex8mined by the Global Burden of Disease study,, ranking number 1 frjr years lost to disability worfdwide. In fact, 5 of th8 top 12 disabling conditions globally are persistent chronic pain conditions.. low back and neck pain, migraine, arlhritl8, 8nd other musculoskeletal conditions. This situation underscores thè urgent ned for continued research to better understand and manage chronic pain. The Pain Research Institute and other Foundation-funded laboralories remain committed to addressing the many Complexitles that still surround this condition. With the Foundation's ongoing 10
support, the Instltute has established a robust academic foundation, enabling a rigorous and forward- thinking approach to Ghronic pain research. The Pain Research Institute PRI The Pain Research Institute (PRI) based within the Clinic81 Science Centre at University H08Pltal Aintree was created to support academics and clinicians involved in chronic pain research. St provides platform for pain r888archers across the Liverpool region, including NHS institutions and other universilies. Research conducted within, and in collaboration with, the PRI ranges from small laboratory experiments to large clinlcal Idals. Involving healthy volunteers and patients with pain disorders They are located direclty adjacent to the Walton Centre NHS Foundation Trust, Liverpool. The dominating factorfor our location here is because pain-related research prolects often need access to a large number of patienls. The Pain Clinic has a through-put of over 4500 new patients each year and access to this patient base is paramount for the Paln Research Institute to continue with their work. The symbioti¢work that is carri8d out in liaison beiween Ihe Iwo units, and the expertise that hag emerged over the years, has led to the 'Wallon Pain Clinic, becoming, and remaining, the largest and most successfiJl in Europ8. All pallents recruited are fully informed volunteers. Patient and Public Involvement (PPI) is a cornerstone of the Pain Research Institute {PRI). With over a decade of experienGe in hosting r8gular PPI groups, our team works closely with patients to ensure their Inslghts shape every stage of our chronic pain researGh. The Pain Research Institute remains a hub of intense activity. The multidisciplinary research spans a wide rang8 of fields within pain medicine,. all airned at identifying and treating the root causes of chronic pain. Below, highlighled are the current searCh avenues showcasing the promising work undeway to alleviate suffering and improve the quality of life for those affected. Pain Immunology - We fo¢us on the contribLrtion of immunoglobulin G autoantibodies in Causing chronic pain. Paln Management Programme8 - The Pain Research Institute works with the PMP Department at The Walton Centre to ensure that we continually research PMP5 lo help make them as effective as possible. Paln Imaging- Chronic pain leads to changes in the central nervous syslem that are often maladaptive - they make pain worse rather than lessen it. We have used functional MRI to explore these changes in several groups of pain patients Cllnical Trials - Most researchers in the Paln Research Institute conduct clinlcal trials. We are engaged in both investigator-led and Industry-sponsored trials that assess analgesic drugs and int8N8nts'ons The Pain Research Institute has a long-standing history of excellence in the field of chronic pain. Their commitment to advancing the understanding and treatment of pain is evidenced by a robust portfolio of research published in prestigious medical journals and authored by their team of expert consultants. Looking ahead, the Institute's doctots and scientists aim to pioneer new breakthroughs. with necessary funding, these future research inltiatives promise to significantly improve the physical and psychological well-belng of those living with chronic pain Research Accommodation The Trustees of th8 Pain Relief Foundation have continued with the agreed policy that whilst continuing to retain the leasehold and ownership of the Pain Research Building in the Clinical Sciences Centre, together with the fixtures, fittings and equipment therein, they will provide the facility of the Institute, together with the fixtures and frttings, to the Department of NeuroSogi¢al Science, Univer8lty of Liverpool, and to other such parties who are researching chronic pain, or who wish to enter into collaborative research on human chronic pain.
This arrangement will ensure that research personnel supported by the Pain Relief Foundation, the University of Liverpool, the Liverpool John Moores University, and those others who are employed by another party but are working on chronic pain research under the auspices of the 'Pain Relief Foundation, Professor of Pain Science, shall be contained in the same premises and wark collaboratively. This arrangement offers a more structured and controlled working area and is conducive to good working practices. The use of the premises does not Create a lease but shall be treated as a Licence at Will. All of the overhead and operating costs of Ihe Pain Research Institute premises are borne by the Pain Relief Foundation and are allooated as part of the research grants. The foSlowlng 'modus operandi, w8s pursued during the year as in previous years-.
Th8 Pain Relief Foundation provided administration and research accommodation for the research personnel, wilhin the Pain Research Institute. The Pain Relief Foundation provided limited secretarial assistance to the associated research personnel, from its own employed staff. The Pain Relief Foundation discharged all $t$ connect8d with the accommodation ofthe Pain Research Institute and its operatlonal f8¢ilities, including overheads, heat, light, repairs, and purchase of new equipment etc. Th8 Pain Relief Foundation discharged all costs connected with th6 provision of all consumables and computer hardware for the Professor of Pain Science and all other grant aided Researchers working in the Pain Research Institute. The Pain Relief Foundation dlscharg8d all costs connected with the provision of18cture theatre and associated facllitles. Under the pr8senl structure, the 2 Heads of the Pain Research Institute are charged with r8porting to the Trustees in respect of all research work carried out under the Pain Relief Foundation grant arrangements, and also on th8 additional research that has been mad8 possible through the Foundation's fundlng and provision of accommodatlon. This 88tablished procedure 18 an essential method to evaluat8 and measure the success and effectiveness of the research work being conducted and to ensure that it is achieving its aims. They also maintain a liaison with the Scientific Committee and Education Sub-committee, attending their meetings in an Ex-officio capacity. RESEARCH COQ)RDINATION & EDUCATION The research co-ordination accommodalion is located in the administrative area and fulfills a range of functions in its operational role. It supports the Pain Resear¢h Institute in several fields, providing accurate sources of scientific and medical information to assist the researchers in many projects. Under the direction of the Education Sub-committee, the Education Section also undertakes the operational factors in the Conduct of all postgraduate courses that are organised throughout the year, arranging the tea¢hing seminars, overseeing the Pain Relief Foundation Annual Lecture, ¢ollaling and ensuring the ¢orre¢t and tim8ly marking of Studenl essays and organising external conferences. 12
STRUCTURE GOVERNANCE AND MANAGEMENT Governlng Document On 6* April 2014, the Pain Relief Foundation was incorporated as a Charitable Incorporated Organisation under Charity number 1156227. Structure Gov9rnance & Mana ement The Pain Rellef Foundation is controlled by its Constitution as a Charitable Incorporated Organisation managed by a Committee of Trustee5 and at their meetings the Committee regularly conducts an assessment and review of their number, taking into account the sknll requirements of the members in conducting the affairs of the Trust, and any potentia5 retirements in the forthcoming 12 month$. From this review, consideration is given to the need, if any, to recruit further Trustees. In the event that further recruitment is deemed necessary, the Committee of Trustees will seek suitable candidates through a process of personal contact across the Universities, the Health Service and other appropriate professional bodies associated with the charity. Details of the Trustees are shown on page two of this report. The power to appoint a new Trustee or additional TNstees of the charity Is vested In the Committee of Trustees and new appointments may be made by a resolution of a rneetlng ofthal Comrnitteg. A Trustee may retire upon giving two months, notica In writlng of Intentlon to do so to aach of th8 Oth8r Trustees. The Trust Constitution requires that the number of Trustees should not be less than three at any time, but there is no limit on the maximum number and Trustees are not requlred to retire and 8tand for re-election. No expenses of any type will b8 paid to any Trustee, nor wlll any Trustee be paid any remuneration or payment of any kind from the FoundalSon In th8lr capacity as a Trustee. All the Trustees will give free of their time and act in an honorary capacity. This is confirmed in each year's Annual Report & Accounts. In the period 61h April 2025 to 5th April 2026, Ihere were no expenses of any type paid to any Trustee nor were th&re any Trustee in receipt of any remuneration or payment of any kind from th8 Foundation in their capacity as a Tru81ee. All of the Trustees gave free of thelr tlme and acted in an honorary capacity. The Committee of Trustees conduds four quarterly meetings each year at which they receive reports on the acllvities and achievernenls that have occurred since the previous meeting. The meeting agendas enGompass reports on the full range of activities and situations including day-to-day administration, investments and reserves. cash flow and risk management. The Committee of Trusl8es continues to review several areas of importanGe in the effective management ofthe Foundation. The prepared 'Risk Assessment, policy is subjeGt to regular review to ensure that potential risks to which the charity may be exposed are adequately identified, assessed and mitigating steps taken. This operational area is considered to be of the greatest importance, and procedural changes will be implemented if deemed appropriate. Relatsd Parties For the purpose of preparing accounts in accordanGe with the Statement of Recommended Practice for charities, in the opinion of the Trustees, the following are related parties to the Pain Relief Foundation- The Trustees and their immediate family The National Health Service
The University of Liverpool 13
Risk Mana ement The trustees have a duty to identify and review the risks to which the charity is exposed and to ensure appropriate controls are in place to provide reasonable assuran against fraud ancl error. Risk Assessm8nt The Trustees have prepared a risk assessment register in which they have recorded the details and results of an extensive study regarding the potential risks to which the charity may be exposed in the conduct of ils alfairs. The Trustees have satisfied themselves that through the actions they have taken, the identified risks have been reduced or eliminated, and that appropriate procedures and controls to deal with the risks are in place, so that any resulting or potential impact that the charity may experience is minimised. The risk assessrnent register is subject to at least an annual review and in géneral it is an ongoing review. SuGh reviews 8nsure that all of the procedures in place continue to be appropriate to the conduct of the charity and that it 15 adequate in th8 light of experience. Whère appropriate, systems or procedures have been e6tabllshed and put into plac8 so as to miligate any risks which may arise or develop Trustee Indemnlt Insurance The Trustees do not contract a Trustee Group Indemnity Insurance pollcy. Recrultment A ointment and Inductlon of New Trustees In selecting people to be appointed as trustees, nominations are submltted to a meetlng of the Committee of Trustees, so that they each have the opportunity of evaluating the strengths of the candidale(s). In considering each nominee, thé trustees take into account that person's professional qualifications or p8rsonal qualities, Ihèlr commitment to promoting and furthering the aims of the Foundation, and their ability to make a contribution to the effective management of Ihe Foundation. If the nominee 18 de8med acceptable. then the appointment 1$ conducted in accordanc8 with the established procedure of induction and training. The Chair of th8 committee will extend an invitats'on to the candidatelsl to attend an early me8ling to discuss the appointment in more detail. This is followed by a further meeting with the committee of trustees at which the new trustee Is introdu¢8d, and a formal appointment confirmed. On appointment, the new trustee is required to sign a declaration stating thatthey comply with the fomal conditions required of a Truytee and are therefore able to legally serve as a Irustee. It is a requirement that a declaration of interest be made so that any conflicting interest is noted and registered accordingly. Should any interest be registered, then at any meeting wh8r8 there is such a confliGt, the Trustee will be required to withdraw and not vote on the matter. It is also declared that none of the Trustees have an interest in th8 phannaceutical industry. However, any such interest would be registered. An induction meeting is then held with the Administrator who will inform the new Trustee of their powers and responsibilities, the operational policy, the managament arrangernents for the charity'5 investment funds and the procedure of receiving applications for research grants and how the applications are processed through selection. Other meetings are then held with the Sub- Committees at which their operational roles and powers are discussed. An induction welcome pack is provided for the new Trustee, which contains a copy of the Constitution, Copies of the Trustee Committee's meeting minutes and the meeting minutes of the Advisory Sub-committees, each covering the past 24 months, cash flow reports for the same periods, and copies of the previous two years, Annual Report and Accounts. A presentation folder is prepared containing copies of the Reserves Policy. Risk Assessment, Managemenl Flow Chart, ission Statement and Equal Opportunities Policy. In addition, a copy of the Charity Commission's publications. 14
Education Adviso Sub-committee Appointed by the Committee of Trustees, this sub~committee is the driving force behind the Foundation's educational and informational outreach, ensuring that knowledge is not only generated but effectively disseminated lo those who need it most. Chaired by Dr. Manohar Sharma, a distinguished Senior Pain Consultant within the N.H.S. and a dedicated Trustee of the Foundatlon. the sub-comrnlttee exempllfies a unique blend of cllnical insight and strategic vision. Its composition speaks volume5 aboutthe depth of expertise al its disposal, inoluding leading Neurosurgeons, Senior Pain Cliniclans, and a Cllnical Lecturer with a Speclal Interest in Pain. The primary rnandate of this sub-committee is to advise the Trustees on all educational issues and to robustly develop the Pain Relief Foundation's eduGalSonal footprint. This is achieved through a mults- faceted approach, encompassing..
Publlcatlons: Developing and endorsing high-quality written materials. Courses & Lectures: Designing and delivering educational programmes for health professionals. Llterature & Conferences: Organising and particlpatlng In forums that foster knowlèdge exchange and collaboration. Beyond direct educational programmes, the commitiee plays an equally crucial role in Ihe dissemination of vital informatlon. They are specifically tasked with identifying the most appropriate methods for publlshing and sharing.. Su¢ces$ful Research Results: Translating complex findings into accessible formats. New and Improved Treatment Methods: Providing updates on the latest advanc8ments in pain care. Information Leaflèts for Pa5n Sufforer8'. Empow8rlng patl8nts by dlrectlng them to Ihe best treatment resources and centres. This Information is distributed through the medical press and both the Foundation's website and the Institute's website. All of the members act in an honorary capacity. Sclentlflc Adv180 Sub-commltte The committee Is responsible for advlslng the Trustees on the stratsglc allocation of funding for research projects and grant applications. Under the leadership of Dr. Caroline Staunto dlslinguished and formidable research associa1the panel benefits from expert guidance. Dr. Staunlon's flrm, equltable approach ensures Ihal every funding decision is rigorously evaluated based on sciènllfic merit. potential Impact, and alignment with the Foundatlon's core mission. Her fellow committee mèmbers aré meticulously recTUlt8d for their profound and in-depth knowledge of chronic pain condilions. Drawn from both local and external treatment cenlres, they represent the myriad disGiplines involved in the comprehensive study and treatment of human pain. This diverse expertt'se ensures a holistic and nuanoed evaluation of research proposals. encompassing the many facets of pain science- from neurobiology to psychological interventions and clinical treatment modalities. Crucially, all members dedleate thèlr time and 8xpértise In an honorary capacity The Committee seNes as an indispensable source of information. advits. and 8xpert opinion, particularly in its role of evaluating and prioritising the numerous funding applications for scientific research deemed worthy of support. Their rigorous assessment process is vital in identifying projacts with the highest potential to yield significant breakthroughs. The Committee continues to be the source of invaluab5e information, advice and opinion when reporting on, and priorilising, th& numerous funding applications for scientific research which were considered tD be worthy of support. 11 also continued with the vital task of overseeing the results from the rnany facets of research work, assisting the Trustees in interpreting, and analysing th8 large volum& of scientific infomiation submitted by Research Fellows, Grant Holders. 15
The purpose of receiving and analysing these report$ is to satisfy the Trustees that: The research being funded is achieving the projected resulls to a satisf8CtDry and accepted scientific, medical and research standards.
the research is likely to reach its stated aims. ethical approvals remain in place and are being followed scrupulously. research Governance is being obse¢ved at all times. quality standards are being maintained. the costs of the research are maintained within the grant limlts. the research is being managed and monitored effectively. The head of the Pain Research Institute is ¢alled to attend each of the Trustee meetings to provlde the Trustees with an insight into the advances and the strategic development of the research opportunities being pursued. Reports are also received from the appointed Education Advisory Sub-committee, which is principally involved in directing the Educational Meetings, Lectures, Student Essays aTKI Pali811t Information issues and the Scientific Advisory Sub-commlttees which undertakes the task of advising thé Trustees on all aspects of Research and Research Grant applicalions. Grant Makin Polic In November 8ach year, the Pain ReSlef Foundation advertises in the national médlcal press and social media, to invite well established researchers and scientists to submlt applications for Pain Relief Foundallon grants, to carry out research projects on human ¢hronic paln .The notice to apply for grants Is advertised in the selected medlcal journals, on the Pain Relief Foundation Webslte and social medla, on the NHS grantwebsite and through other appropriate media., there Is a closing dale for the receipt of such appllcalions. The advertisement states the uppér {monelary) Ilmlt of granls, which may vary from year lo yéar. On racelpt of appllcatlons, the Foundation's Charity Manager ensur8S that all appropriate sections of the applScation forms which have been received are correclly completed and then arranges a meeting of Ihe Scienbfic Sub-comrnittee lo presenl Ihe Abstracts of the appllcatlons to the members. At this meeting, the members jointly select and nominate independent and best qualified, learned medical persons who will be asked to peer revlew each selected appllcation to go through lo round 2 and lo glve their expert opinions. After the meeting the Charity Manager writes to the selected peer revieweTS, submitting a copy of the application asking if Ihey will provide an assessment of the proposed research, tha Ilkelihood ofthe work suCeding and the cost effectiveness of the requested budget. In addition, references are sought regarding the appli¢anls and tfve outGome of previous research projects for which they have received funding from all sources, When all applications are complet8 Wlth the peer reviews and references received, a full set of each application is submitted to each mernber of the Scientific Advisory Sub-committee, for consideration and prioritisation in preparation for a selection meeting of the members. At the grant meeting, the Chairman calls the attention of the members to the received Peer Reviews and References which are Feferred to throughout the process of considering the most appropriate and worthy applications deseNing of a grant. Each committee member delivers an opinion on the applications received and scores each application bebmeen 1 and 3 with <1) being the lowest score and (3) the highest score. These scores are then brought together with the Peer Review seores and the applications Ilsted In order of achievement, at which point the Chairman and the cornmittee draw recommendations to place before the next meeting of Ihe Trustee Committee. When the Trustee Committee receives the advice of the Scientific Advisory Sub- Committee, they decid8 which applicatlDns, if any, will be funded in accordance with advioe received, and in the light of funds available. The Trustees may recommend that an application not be funded. be funded in full, or be funded at a reduced level. In the event that the Trustees are considering a number of competing 16
recommended applications for which the Foundation's funds are inadequate to fund them all, Ihe Trustees may invite the Chairman of the Scientific Advisory Sub-committee. together with those members of the Sub-committee who are also Trustees, to help them prioritise the applications. Each grant is specific to the holder and ceases should the grant holder terminate their post. New rants a roved since the last re 1. An applicalion is for a 3-year prize PhD Student for a lolal of £83,478 submlttèd by Prof Karen Ersche of Unlversity of Cambridge and is titled Investigating the neurobehavioural effects of opioid and non-opioid pain medicab'on$. 2. An application for a 12-month grant for a total of £18,787 submitted by Dr Susannah Walker of Llverpool John Moores University and is titled.. Phy&ologlcal Synchrony in ChroniG Pain. 3. An appllcatlon for a 36-month grant for a total of £29,824 submitted by Dr J Southcombe of University Oxford and is titled 'Understanding endometri05is associated pain,. Publlc Bènefit As stated, the Foundation's objectives are supported by a commitment to fostering peer-reviewed, high-caliber research aimed at advancing patient treatment and pain management. Furthermor8, the Foundatlon Invests in the professional development of healthcare practitloners. These activities remain under constant oversight by the Committee of Trustees and Advisory SulFCommittees, ensuring that our strategies remain agile and our outcomes Consistently me8t the highest professional standards. The development of Improved patient services and treatmenl is ¢onsider6d to be a priorlty issue by the Foundatlon, and11 works symbiotically and in co-operatlon wlth the NHS and Unlversities lo provide post- graduate scientific educatlon in chronic pain relief. A number of postgraduate trainlng courses have been conducted each year, for the continuing edu¢atlon of nursés, GPS, and for cllnlcal paln specialists. The Foundation provides 8n essenllal Informatlon s8Nice for both h8althcare professionals and patl8nts. We equip General Practitionefs and pain specialists with the latest update5 on pain management treatments, while offering patients, families, and carers eompr8h8nsiv8 r8sources on chronic pain. Our webslle features a wide range of dowr¢loadable guidance and support materials, empowering indlvlduals lo take an active, informed role in managing thelr ¢onditions. Pain sufferers who make telephone contact with the Foundation are connected to experienced, frlendly staff who are trained to sympathetically and professio)nally direct enquireis through to av8i18ble services and advice centres. They are also able to guide sufferers into how they can avaS1 themselves of these services and what actson they can take to be referred to GliniGal setvices for pain treatment. Patients also receive direct benefit through research results which lead to the development of nèw and improved treatments for chronic pain conditions. These results are delivered to pain treatment clinics ng1iona51y, and indeed internalionally, Ihrough the dissemination of research informatlon by the Foundation either electronically, from our website, in medical publications and by way of educational meetings for health prDfessionals. With living with chronic pain affecting approximately 40Tr/ts of the British population, it can be seen that the work of the Foundation provides a benefit for a huge number of people. Reports on the research work supported by the Foundation are included in later pages and give a vast amount of infomiation on the progress that is being made with human chronic pain, and you are encouraged to read this section. Volunteers The Pain Relief Foundation does not receive any funding from central or local government, the health service, or other official bodies. Instead. the FourKlation depends entirely on donations, gift 8id, legacies. 17
appeals and contributions from supportive members of the public. from generous companiès and from several small trusts. There is a small level of direct fundraising aclivity organis&d and conducted by the Foundation's own staff, supported by one or 0 volunteers, an area in which we would like to increase our support. Additionally, it seeks to secure grants from trusts and the commercial sectorto fund speclfic ressarch projects. The Foundation is not in receipt of benefits in kind, either by way of services. facilities, or donations-in- kind. It does, however, receive some Ilmited benefit from the very small number of volunteers who support the fundraising section in the organisation and conduct of small ev8nts. The Trustees recognize the intangible value of the contribution of volunteers lo the charity and the Trustees are of the opinion that such income cannot be reliably ascertained. However, it is considered that such intangible income is unlikely to be material. Powers of Investment The Constitution provides the Committee of Trustees With the following powers: To administer a bank account in the name of the Foundation at such bank as the Trusteès shall decide. To invest in the name of the Trustees, any monies not required for the immediate purpose of the Foundation, in such securities as they may from lime to time declde as if they wer6 beneficially entitled and whether such se¢uri118s shall be Trustee investments or not and shall have power from time to time to transpose such investments. That any property purchased by the Foundatlon shall be vested in the Trustees appointed for that purpose and the Trustees shall enter into a Oeed of Trust setting forth the purposes and conditions under which they hold the said property in trust for the Foundation and shall with such consent as is by law required deal with the property so vested in them by way of Sale, mortgage, charge, lease or otheNise howsoever directed by the Foundation. Investment Pollc The Trustees have developed an investment policy which it believes will respond to Éhe needs of the on-going adivities of the Foundation. Sufficient funds are retained in investment that will ensure we can respond to all contingencies as they may arise. Equally important is the strategy of investing. The Trustees have discussed their attitude to risk and wer8 happy with the previous Attitude to Risk Questionnaire which categorised their attitude to rlsk as a 5 on a scale of 0-6 where 6 is the highest risk tolerance. The objective is that thls investment policy will produce improved values and income, whilst at Ihe same time safeguarding the short-term and long-term financial needs of the Foundation. The Trustees seek the advice of its Investment Advisors, Rathbone Investment Management Limited and at regular meetings with the Advisors, in-d8Pth reviews are held into the investment portfolio that makes up the reseNe fund. The investment decisions taken by Ihe Trustees throughout this finan¢ial year have proved to help preserve the portfolio as much as possible in the current climate. Supported by the Advisors and making several minor adjustments, for the best possible oulcome the fund has this year seen an increase compared with the end of the Sast financial year. At a joint meeting with their Advisors, the Trustees set an investment policy of 65 % of the funds invested into 'Equity Investments, with a view of maximising the Securities and to invest 350k of the funds into 'Fixed Interest Securities,. The decision to ease the approach with fixed interest investments was a very positive decision at the commencement of the year.
Reserves Polic The strategy developed by the Trustees is to hold a level of reseNes that is deemed to be appropriate from time to time, to ensure that..
The committed and planned research projects undertaken in the short, medium, and long term are sustainable. The Trustees can address any problems that arise, including the1055 of any significant source of income, which might restrict the ability of the Charity in carrying out its objectives. Sufficiènt funds are available to respond to new and important projects that are identified. The Trustees can respond to a shortfall of income in any financial year, that may occur for whatever reason. and which shall enable the research that is already authorised, to continue without a break. In setting the level of reserves, a conservative management style has been adopted that is consistent with the Trustee's responsibilities who have agreed a broad spread sector exposure to increase diversity and to regulate risk. The Trustees have established a position that the level of unrestricted reservos and investments should be adequately sufficient to respond to the above operallonal poli¢y and n88ds. Th8refore, the Trustees have agreed with the following.. To provid8 r8serv8S to cover the estimated c06ts of funding existing research, research coming on-line, overheads, research administration support, charity administration and fundraising over three years. Based on average annual expenditure, this need is £1,270,245 To rotain investments, an amount that will enable the Trustees to respond to new and important projects that may arise. In arrivlng al a level of retention, consideration has been given to the fact that such projects may require funding for at least years and possibly three years. It Is considered thal in view of th8 ongoing investment market volatility and with the unsteady present UnrtaIntieS worldwide, the present level of reseTve5 is adequate lo meet these criteria. Tradin Changes in the 2000 Finano Act, Chapter 17, allowed exemption to18x on charitable incorne from trading activities up to predetermined levels. The Charity continues to carry out a very small level of in¢idental trading within the prescribed Ilmits. FR fuliDE14lSI. REGVtATOA FUNDRAISING REGULATOR The Pain Relief Foundation is a Member of the Fundraising Regulator (FR) and has been since its inception in 2016, The FR is the independent regulator of charitable fundraising and was s?t up following the Etherington review of fundraising self-regulation (2015) to strengthen th8 SySt6m of regulation and restore public trust in fundraising. The Fundraising Regulator IFR) is open to all fundraising organisations, suppliers, and associates. Members commit to the highest standards of practice and uphold the Fundraising Promise. Displaying the FR logo on all fundraising materials signals this commitment, assuring the public that 19
the organisalion follows best practices and provides a robust complaints process as a vital safety net. It is a requirement that a charity submits an annual report to the FR, advising the Board of the number of complaints received by the Charity, in relation to Its Fundraising activity, by category. The report requir8s the charity to notify the Board of action taken to resolve any such complaints and what the outcorne results are. Pain Relief Foundation Is pleased to report that in the year ending 5th April 2026, no complaints had been received by the charity in the preceding 12-month period. A report to this effect was submitted to the Board of the FR as required. The Pain Relief Foundatlon Fundraisin Prornlse We are always committed to working to the highest standards of practic8. We promise donorg that we will cornply with the FR Codes of Fundraising Practice and do all that we can to ensure that fundraisers and volunteers will at all times comply with the Codes and with this Promise. We comply with the law. health and safely and the environment. W8 will not put unfair pressure on anyone to donate. Ifyou do notwantto donate, we will respect yourdecision. We require anyone fundraising on our behalf to clearly identify themselves as one of our r8pres8ntatives. We are honest and open and do not make false or exaggerated claims. We do what we say we are going to do and do not pretend to do things that we cannot. We will answer any reasonable questions you have about our fundraising activllies and costs. Please ¢ontact us for information, vlsit our website or see our Annual Report. We are clèar and give clear detalls about how you can make a gift. If you make a regular gift and you want to cancel it, w& will carry out your canc&llallon instructions as soon as possible. Vve are clear about whal we do and how your gift is used for the effective support of our beneficiaries. We are falr and respect the rights, privacy, and dignity of each of our supporters and beneficiaries and conform to the Data Protection Act, We will only use your personal information for the purposes stated and for which you have given your consent. If you tell us that you do not want us to conla¢t, you in a particular way (e.g., by telephone) w8 will not do it. We are reasonable and responslblo and will be careful not to use any images or words Ihal cause distress or offence. We make sure that our events are well run and meet health and safety and environmental requirements, and we avoid causing any nuisance, damage, or disruption. We will not use excessive emotional arguments to make you feel guilty about not giving to us. Wo are accountable and should you be unhappy about anything we have done whlle fundraislng, you can write to us and complain. We have 8 complaints procedur8, and we will aGknowledge your complaint within 7 days and Commit to dealing with the matter within 30 days. A copy of our proceduro is available on request and if we are unable to resolve your complaint, we aGcept the authority of the FR lo rnake a final adjudication. DONATION POLICY This policy h8s been set out by the Trustees of the Pain Relief Foundation. It is a public guide to how the P8in Relief Foundation makes decisions on accepting donations and the procedures they follow. The policy is aligned with the codes of Fundraising Practice published by the Institute of Fundraising. 20
This document makes clear the Trustees, legal obligations with the regards to the acptance and refusal of donations. It outlines the day-to-day procedures that need to be adhered to and ensures decisions are not taken on an ad-hoG basis but are in support of Pain Relief Foundations strategies and objectives. Trustees, legal obligations The Trustees take overall legal responsibility for decisions relating to whether a donation can be accepted or refused. The Trustees must b8 able to demonstrate that they have acted in the best interest of the Charity. The Trustees have a duty to cafUllY, basèd on 8videnc8 made available to them, whether thè Charities interests will be better served by accepting or refusing th8 donation and to act accordingly. These judgements must not promote any Trustee or employee's personal moral agenda, or interest and the Trustees must not allow individual or colledive pèrsonal, political or ethical issues, which are not directly related to Interests of the Charity, to affect theirJudgment. Trust88s must not derive any personal benefit lindlvidually or ¢ollectlvelyl from donations, offered to the Charity. Policy On a day-to-day basis, the Charity's board of Trustees delegates the responsiblllty lo accept or refuse donations as follows, provicling Ihe Charity Manager is sure Ihat any potential individual or corporate donor are supporting the charity in accordance with this policy.
A donation must be clearly evaluated to establish whether it would be in the best interest of the Pain Relief Foundation to accept or refuse it. The donation should contribute towards the Charity's overall strategy and plans. The Charity will not acc8pI donations from individuals or companl&s whose wealth are known to result from illegal activities or where there are indications of corrupllon and related crime. The donor's objectives or activit16s must not appear to be incompatible with the Charlty's Vl8ion, mission, and values, particularly rf this risk is causing significant damage to the Charity's integrity, public image, or professional reputation. The Paln Rellef Foundatlon will refuse donations in the following clr¢umstances: ere the activities of a donor are directly contrary to the objectives or agreed policies of the Charity or the Charity suspects the gift has been donat8d to facilitate money laundering or olher criminal activity. ere it can be clearly shown that the cost to thè Charity of accepting Ihe donation will be greater than the donation itself, and that the a¢¢eptan¢e of the donation will directly lead to net decline in assets of the Charity. Where the offer of support is dependent on the fulfilrnenl of rta1ft Conditions placed upon the Charity and any Gondition, A) Is in itself contrary to the obj&ctives of the Charity 21
B) Is regarded as needing an unreasonable level of support from the Charity especially in relation to the size or impacl the donation will have on the Charity's charitable aBtivities. C) Will divert the Charity from pursuing its current objectives, policies, or work priorities as a necessary fulfilment of the conditions alone. The Trustees will take great care and consideration in deciding whether to accept or rofuse a donation. Donation Rècognition Glft Acknowledgment & Accountablllty
All donors will receive a porsonal thank you letter and receipt, regardless of gift amount. All gifts will be formally acknowledged as quickly as possible, and in any @vent wilhin S working days. The reporting requirements of all Grant Makers will be fulfilled thoroughly, accurately and within their required timeframe. Major donors for specific projects wlll receive where réquired and appropriate regular updates on the progress of the project. Where appropriate and required the families of legacy donors will receive a report on the use of the bequeathed funds. Recognition Any donors expressed desire for anonymity will be strlctly adhered to Any public recognitlon wlll only be undertaken with the Donors &xpress permission and in compliance with data protection legislation and best practice. Recognition may be tangible by way of a physlcal acknowledgment such as a plaque and would be placed within the Pain Relief Foundation. Thi8 type of recognition would be decided by the Trustees. In general costs of r8¢ognition shall not exed Syo of the gift amount. In all cases the cost of recognition shall be both reasonable and proportional. rhe Charlty reserves the rlght to refuse. discontlnue or remove publ1¢ ro¢ognltlon whethertangiblo or Intanglble, at any tlme If for any reason it considors tho 8ssoclatlon to bg damaging to Its reputatlon. Thls course of a¢tlon wlll bo d6¢ided by tha Trustees. STATEMENT OF TRUSTEES RESPONSIBILITIES The Trustees are responsible for preparlng the Report of the Trustees and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). The law applicable to charities in England and Wales, the Charities Act 2011, Charity (Accounts and Reports) Regulations 2008 and the provision of the Constitution requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources, including the income and expenditure, of the charity for that period. In preparing those financial statements. the trustees are required to. select suitable accounting policies and then apply them consistently. observe the methods and principles in the Charity SORP. 22
make judgments and estimates that are reasonable and prudent. prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in business. The Trusteès are responsible for keeping proper aOuntIng records which disclose with reasonable accuracy at any time the financial position of the charity and to enable them to ensure that the financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) R8gulations 2008 and Ihe provisions of the constitution. They are also responsible for safeguarding the asset5 of the charity and hence for laking reasonable steps for the prevention and detection of fraud and other irregularities. The Trustees present their report wlth tha financial statem8nts of th8 charity for th8 year ending 5th April 2025. The Trustees have adopted the provisions of Accounting and Reporting by Charities.. Statement of Recommended Practice applicable to charities preparing their accounts in accordance with Ihe Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102). Approved by order cf the Committee of Trustees on 8th September 2026 and signed on its If by.. Mr. D Cain- Chair Dat8 8th September 2026 CLINICAL SECTION Patlent & Publlc Informatlon The Pain Relief Foundation IPRFI supports those Ilvlng wlth chronlc paln by provldlng expert guidance and resourc8s. Through our webslte and educational leaflets, we help individuals better understand their condltlons and explore potentlal treatment options Onllne Help and Advlce Our website, www.pginreli8ffoundation.org.uk, Is a comprehenslv8 online resource for chronic pain 8uffereTS. It offeTS a wealth of information on varlous aspects of chronic pain, Includlng its ¢auses. symptoms. and available trealmenls. The website also features an online help and advice service, which allows users to submit their queries and receive expert guSdance from the PRF'S team of medical prof8ssionals. Informatlvo Leaflets Beyond our online support servlces, the Pain Relief Foundation offers a comprehensive library of leatlets covering various chronic pain conditions. These resources have helped thousands of patients better understand their symptoms and treatment options. Each leafiet is regularly updated in line with Centre for Health Information Quality guldellnes to ensure the content remains accurate and accessible. They are available foi download on our website and are also distributed to GP practices. CD'S The Coping with Pain CD was one of the early self-help aids for chronic pain sufferers. Wrth an introduction by Magnus Magnusson, it soon became part of the pain patient's medicine cupboard. Each section ofthe CD has been specifically designed to focus the minds of pain sufferers on ways of easing their pain through relaxation and gentle exercise. As many as 2 out of 3 people who have 23
used it report that they have been able to improve their quality of life and find that their chronic pain problem is eased. Over 65,000 copies of the Coping with Pain CD have now been distributed through a range of outlets covering the medical field and the retail sector. Additional CD'S dealing with specific pain conditions are al8D available and they include.. Coping with Headaches & Migraine, Feeling Good, Coping with Back Pain and Relaxation and Coping with Anxiety. Each of the CDS Gontains relaxation programmes that help so rnany sufferers to find relief. PAIN RELIEF FOUNDATION INFORMATION SCIENCES RESEARCH CO-ORDINATION & EDUCATION Introductlon Leveraging the 6xp8rtisè of pain clinicians, this dèpartment works In close alignment with the Foundation Education Sub-committee. Our remit is to ensure the Foundation meets its educafjonal obligatlons by managing all conferences, meetings, and training courses for healthcare professionals. Additionally, the department provides administrative 8UPPOrt for these Iniliatlv8s and man8ges patient and publi¢ information resource$, inclufjing a comprehensiv8 online portal dedicated to chronic pain EDUCATION Meetln s and Coursgs Meetings and courses which are developed and structured are aimed at all hèalth care professionals with Ihe sole purpose being to educate participants 8bout all asp8Cts of chronic pain management. Originally focused on a natlonal audlenc8, our programs have galned Internation81 recognltlon. now attracting partlclpanls from a¢ross thè globe. Foundation cour$es & lectures Planning is well underway for our annua5 Cllnlcal Management of Chronlc Paln course. Designed as 8 vibrant, hands-on clinical experience, this 2.5-day program is tailored for Consultants, Specialist Registrars, Anaesthetists, Advanced Specialist Nurses, GPS, and Physiotherapists with exisling experien in pain management. Thls yearfs ¢ourse is led by Dr. Hemkurnar Pusharaj and Dr. Manohar Sharma, both Specialists in Pain Medicine at The Vvalton Centre NHS Foundation Trust, wilh expert support from Consultant Cllnlcal Psychologist Dr. Kerry Matthews. We are committed to continuous improvement,. we carefully review all participant feedback annually to ensure our Curriculum remains at the forefront of the field. The course features a dynamic blend of lectures, seminars, Clinical observations, theatre sessions, and grand rounds. A highlight Dfthe program is a dedicated day wilhin The Walton Centre's Pain Management Programme, where participants gain firsthand insight into multidisciplinary patient assessments and evidence-based treatment pathways. The Foundation continued in its role of facilitating the North England Pain Group (NEPG) one-day meeting in Leeds. This year's programme was organised by Dr Karthik Dhandapani, Consultant in Pain management at York Hospitals. The meeting covers many topical and highly relevant areas in the current Practi of Pain Medicine. With organisation underway the 25th Pain Rellef Foundatlon Annual Lecture will take place in October. This yearwill honour the late Felicia Cox, Nurse in Consultant Pain Managernent 24
The eulogy will be given by Dr Gill Chumbley, Registered Nurse and leading expert in pain management. The Lecture will be delivered by Prof Candy Mccabe, Clinical Academi¢ Nurse, University of the West of England, The Foundation biannually hosts the EFIC Liverpool ter Cancer Paln School, aimed at educating young European doctors and allied health professionals in cancer pain management. The next course, led by Dr. Manohar Sharma (Consultant in Pain MedicinelFoundalion Trustee), wlll take place in October 2026. This 4-5 day intensive program focuses on evidence-based assessment and treatment. Capacity is limited to 25 attendees.. 15 plaGes are EFIC-funded for European dodors, with 10 spots reserved for intemational and UK-based delegates. Further information regarding our education courses Is avall on our websit6 under the events section The Foundation Essa Com etition The competition is run annually. The aim of thls ¢omp8tition is to raise awar@ness nationally among medical undergraduates about chronic pain and the Pain Research Institute. The competition 18 open to multiple dlscipline entries Medlcine and all health profession Undergraduates including occupational therapists, physiotherapist, nurses, and psychologists. The winning entries for 2025 are below.. Flntan Conwayi Unlverslty of Edlnburgh - Rethinking Pain." The Gut Mlcrobiome as a Novel T8rget in Inflammatory Arthritis. Vernon Fernande$, The London School of Medlclne and Dentl8try- Digital Twins & Artificial Int811igance.' Red6lining Equilable ChroA7ic P81n Management. samuel Brown, Unlverslty of Cambrldge - Thg 'Gut-Br8in-P8in Axls, In Chmni¢ Ivigraine.. rhe Ther8p8Utic Role ofDiel and Probiotics. Each winner received the winning prize of £500; their essays can be vlewed on our webslte. Paln Relief Foundatlon Webslts The Pain Relief Foundation websrte (www.painrelieffoundation.org.uk) is our primary resource for evidence-based chronic pain information. We connect patients with expert- vetted guidance, provide downloadable self-heSp resources, and publish regular insights froni leading clinicians. In addition to our patient resources, our site serves as a vital community hub for fundraising news and a professional portal for healthcare training and events. WORK & STUDY AREAS The Institute continued to provide aGcommodation for research personnel to study their research developments and prepare research reports and applications. The accommodation is fumished and serviced, fully set out with computers workstations, and associated equipment. 25
RESEARCH Below are a snapshot selection and brief description of research that is currently being undertaken with the support ofthe Pain Relief Foundation. An in-depth progress report of the research can be found on our website. www. painreleiffoundation.org.uk under the tab marked research. Grant title: The Role of Glucagon-Like Peptide-1 In Migraine Awarded to.. Dr Olivia Grech, University Birmingham. Introduction Migraine is a common neurologica disorder affecting more than one billion people worldwide and Is one of the leading causes of disability globally. Despite the development of newer migraine trèatments, Many patients still do not achieve sufficient symptom relief. highlighting the need for additional therapeutic approaches. Migraine involves the activation of pain pathw8ys linked to the trigeminal system, which can lead to headache pain, sensitivity to light and sound, and other neurological symptoms. During a migraine attack, the Irigeminal neNes release proteins such as calcltonin gene-related peptide (CGRP), which plays an important role in triggering and amplifying migraine pain. Glucagon-like peptide-1 (GLP-11 is a naturally occurring hormone released after food intake that helps regulate blood sugar levels and appetite. GLP-1 receptor agonists are now widely prescribed for diabetes and obesity treatment. Interestingly, ernerging evidence has also suggested that th8se drugs may have protective effects within the nervous system and could be beneficial in neurological dlsorders. We hypotheslsed that GLP-1 may be an effective therapy for migrain8 and it may act via altering CGRP release. Thé rlma alms of thls work were: 1. a) Assess the effect of GLP-1R agonism on cllnlcally relevant phenotypes by maasuring mechanical thresholds after acut8ly administering a migraine trigger. bl Assess the effect of GLP-1R agonism on clinically relevant phenotypes by measurlng mechanical thresholds after chronically administering g migralne trigger. 2. Assess the effect of GLP-1R agonism on processing pain signals related to headaches by measuring neuron firing in the trigeminocervical complex (TCC}. 3. Determina th6 effects of GLP-1R agonlsm on CGRP expression. To address these aims, we used cllnlcally relevant preclinical migraine modèls and combined behavioural, electrophysiological, histological, ar)d biochemical approaches. Results GLP-1 and Mi raine-Related H ersensitivit This funding enabled us to establish and apply preclinical models that capture key features of migraine-relaled sensitivity. These approaGhes allowed us to assess sensory changes relevant to headache and facial pain, including in models designed to reflect both short-temi and more persistent migraine-like states. Using these models, we were able to explore whether GLP-1 receptor activation influences migraine-related hypersensitivity. The findings provide encouraging preliminary evidence supporting further investigation of GLP-1 signalling in headache-related pain. GLP-IR Activation and Mi Taine-Related Neuronal Activi 26
The projert also supported studies examining migraine-related activity within brain regions involved in prosSing headache pain. This allowed us to investigate wh8th8r GLP-1 receptor activation can influence central pain-signalling pathways relevant to migraine. These experiments provided valuable mechanislic insight and helped strengthen our understanding of how GLP-1 signalling rnay interact with neuronal pathways involved in migraine. GLP-1R Activation and CGRP Si nallin As CGRP is a key molecule involved in migrainè biology, we investigated whether GLP-1 receptor activation could Influen CGRP-related signalling. The funding enabled us to assess this pathway using both tissue-based and migraine-relevant experimental approaches. This work generated preliminary evidence that GLP-1 signalling may interact with CGRP-related mechanisms. Given the importance of CGRP in current migraine treatments, these findings support further investigation into how GLP-1-based approaches may complement or inform existlng therapeutic strategie5. Overall, this project has provided an important platform for exploring GLP-1 receptor slgna15ing as a novel pathway of interesl in migrain8 research. The funding enabled us to develop and apply linically relevant preclinical models, generate preliminary mechanistic dala, and strengthen the evidence base needed for future sludi8S. Grant title; Biomarkers In Burnlng Mouth Syndromg, Awardod to: Dr Franois O'N8iI, Universlty LIVeO01. Back round to ro ecL The project's main aim is to test whether Corneal Confocal Microscopy ICCM) can be used as a surrogate to tongue nerve fibre density in Burning Mouth Syndrome IBMS), Prior studies in the literature have shown Ihat the density of small diameter neNe fibers is reduced in the tongue mucosa of BMS patients. This is similar to that seen in skin biopsies of other small netve fi'bre neuropathy conditions. Also, we recently showed that in a small pilot study that BMS demonstrated a reduction in nerve fibre density as seen in the cornea of the eye by CCM. To allow CCM to be used as a new non-invasive biomarker test in BMS patients we first have to show the amount of neNe fibre density change seen in both tests are similar and can be diagnostically accurate. To do this we are collecting tongue biopsy samples from patients with Burning Mouth Syndrome, {invasive procedure} preparing these samplgs to look at under a microscope to counl the number and density of nerve fibres in the surface lay8r of the tongue. Separately, we are performing Corneal Confocal Microscopy, (non-invaslve procedure), in the same patients lo provide a count of nerve fibres and density as seen on the surface of the eye. We then compare the data from both samples lo see if they are in agreement. If so, this will allow CCM to be used to facilitate interrogation of the hanges in netve fibres seen in this condition throughout the duration of the condition and during potential treatments. A further objective of the study is to examine whether immune colls are increased in this group of patients. During the previous pilol study, we also showed that there was an increase in the number of Langerhans cells present in the cornea of BMS patients. This number was up to 3 fold higher than nomial. This has not been investigated in tongue biopsies and so together with the evaluation of nerve fibre density in these samples being collected we are also looking at the presence and spatial orientation of Langerhans Gells and their position relakn've to nerve fibres. Pro ect ro ress Recruitment: 27
Target recruitment - 60 BMS patients and 20 healthy controls Present recruitment numbers - 45 BMS patients and 18 healthy controls Present recruitment numb?rs are good with the femaining participant numbers on targel for r8cruitment in the present study timeframe. Sample prooessing: Samples from both BMS and healthy controls are presenlly being prepared for processing with some optimisation of protocols for staining of nerve fibres and Langerhans cells on biopsies. CCM and Blink reflex testing: Dr Jamie Burgess is being train8d up to do blink reflex testing and will then timetable patients lo attend for CCM and blink reflex testing on the same visil. This is starting in June 2026. El8ments of study still to complete: A further 15 BMS patients and 2 healthy Gontrols to recruit and $8mples taken. ReGruitmènt is actively UndeaY and a push is being made to complete this as soon as possible Once 811 sarnples are prepared then proce8sing and slalning to be finallsed. Analysis of n8rve fibre density of both biopsies and CCM data and comparison made 28
eTMR Limlled Statutory Auditor C•ntury Building$ 14 St Marls Parsona9* Manch88ler M3 2DF
Report of the Independent Auditors to the TTUStees of Pain Relief F?undation Opinlon We have audited the finan¢ial 51alements of Pain Relef Foundation Ith& 'charitable company'l for the year ended S April 2026 which comprise the Statsmenl of Financial Activities, the Balance Sheet, th& Cash Flow Statement and notes to the financial statement5, including a summary Df significant accounting pollcie$. The finan¢lal reportlng framework that has been applied in their preparation is applicable law and Uniled Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). In our opinion the financial 5tatemenls'. - give atrue and fail view of the slate of the charltys affalrs as al 5 Apdl 2028 and of ils irming resources and application of resources, including it8 income and expenditure, foi the year then ended.. have been properfy prep8r8d in aecordanc8 with Unit8d Kingdom Gènerally Accepted Accounllng Practice., and have been prepared in ac¢ord8n¢¢ wllh th& requirements of the Charities Act 2011. 8a81$ for opinlon We conducted our audit Èn 8eeordanc& with Internation85 Standards on Auditing IUKI IISAS IUKII and appllcable law. Our re$pon5ibililiÉs undfrr those standards are further described in the Auditors, re8ponsibllilies for the èudlt ol Ihe financial slalemenls se¢llon of our report. We are independent of the charitable cotnpany in Accordance with the ethical iequlr¢menls that are relevant to our audil of the financial slalements in the UK, including the FRC'S Ethical Standard, and we hav8 fulfillad our other ethical responsibililies in accordance wilh Ihesg reqU1Ments. We be15eve that Ihe audll Évidènce we have obtained is sufficient and appropriate lo provide a ba¥ls for ouc opinion. ConcluBlong rolatlng to golng concern In auditing the financial staternenls, we have concluded that thè Iruslees, use of the going concem ba318 of 8ccounllng In the prepaiation of the tlnanclal slalemonls 1$ approprlatg. Based on th• work we hav¢ performed, we have not Identified any malerlal uncerta1nties relating to even18 or conditions that, indlvidually or ¢olle¢tlvely, may cast Slgnificant doubl on the ch3rS18bl8 company's abilily lo continué a8 a going concem for a p8rlod of 8t least tw•lve months from when the financlal 81alements are 8ulhorl$ed for issuè. Our re$pon8ibllities end th¢ re$ponsibllltles ol the trustees with rèspect to golng concem ar8 d88crlbed In the relèvant $ecllon$ of thls report. Oth?r Informatlon Thé Irust•ès ai8 r8spon55ble for Ihe other Informatlon. The other information ¢omprl8OS tha informalSon Included in Ihe Annual Report, olhgrthan the financial slalements and our Report of the Indèp•nd8nt Audltors theon. Our opinlon on thé financial statements does not cover the othèr informallon and, except lo the extent olhgrwl¥e explldtly slated in our report. we do not express any lorm of 8ssurgn¢o ¢oncluslon thereon. In connecllon with our audit of thè flnancl81 stalements, our responslbllily is to fead th& othgr Infomation And, In dolng so, consider whether the other Informatlon Is materially inconsi8t8nt with the fin8nclal stat8ments or our knowledge oblain&d In the audit or olherwise appears to be materially misslaled. Ifwe idÉntify such materlal Inconsistencies or appaignl material misstatèments, we are required to determine whether this gives rfse lo a material misslalemenl in the financial statements th•msèlv&s. If, based on the work we have performed, we conclude that there is a matsrial misslalemenl of Ihls other inlormatlon, we are required to report that fact. We hav8 nolhin9 to report in this regard. Matters on whlch we aro requlred to report by tx¢eptlon Wè have nothing to report In respect of the followlng matlers where the Ch8ritles (Accounts and Reports) RegulatSons 2008 requlres us to report lo you if, iri our opinion.. the information given in the Report of ltte Trustee8 13 in¢onsistÈnt In any material Tespeei with the financS01 $tstements', or thè eh8dty has not kept adequate accountlng records., or the financial statements are not in agreement with the accounting records and returns.. or we have nol received all the infomialion and explanation8 we requir8 for our audit. Rèsponslbllltles of trustees As explained more fvlly in the Statement of Tru51ees' Responsibili11¢s, the trustees (who are also thè dirÈctors of the charitable company for the purposes of company lawl are Tespon8ible for the preparation of the financtal $181emonts and for lg tsalisfied that they give a true and fair view, and for such intern81 control as the trustee5 delerniine is neceES&ry to enable the prgparativn of financial statements that are free from material mis$l8lemenl. whether due to fraud or error. In PTeparing thè financial statements. the trustees are r&sponsibleforassessing the charitable cotllpanvs ability to continue 8s a going concern, dlscloslng, as appllcable, matters related to going concem and using thè going cOnr basis ol accounting unless the trustees ¢ilh¢r intend lo liquidate the charitable company arto ceasè operalons, or have no realistic allemativè bul to dts so. 30
Report of the Independent Auditors to the Trustees of Pain Relief Foundation Our re5ponsibilitTres for the audlt of the flnanelal ststements We have been appointed as audilors under Sectson 144 of the Charities Act 2011 and report in &cordance wlh the Act and relevant regulation3 made r)¥ having èff8et Ihèr8und8r. OurobjÈctivès arèto obtain reasonable assurance aboutwhetherthe financial statements as a whole are freetrorn material mis5tatgtn¢nl, whether due to fraud or error. and lo issue a Report of thè Independent Auditors that in¢ludèx our oplnion. Reastsnable assurance is a high level of assurance, bul is not a gu8ranlèÈ thai an audit conducted in ac¢ord8n¢e with ISAS {UKI will always detect a rnaterial rnis3talemenl when it exists. Mls8lalomenl8 can arise from fraud or orror and a c0n8lded material if, individually or in the aggregate, they could reason&bly be expected to influence the economic dÉ¢i$ions of users taken on thè basis of th•sè finarti81 statèm8nts. The extent to which our procedures are capablo of dele¢llng ImgularStles, InGludlng ffa(Kl Is detslled below.. Our approach lo identifying 8sJÈssing lh8 risks of matèrial misstatement in r&sp8Ct ol irr8gularitias. including fraud and non-compliance with laws and regulations, w8$ as hllows.. . we identified the significant laws and regulations applicable lo the charlty whlch w8 ¢on8ldered could have a dlre¢t material effect on the financial slalernenls or the operalions of the chaiily. Said 58ws and regulations include but 8r8 not Ilmiled lo Ihe Charities Act 2011. t?atIon legislation and data protection, 8nli-brybery and employmènt lagislalion., the identified laws and regulations were communicated wilhln the audll team regularly and the learn remalned alert to In81ances of non.cofflplianca Ihrou9houl the audll. We assessed the s¢J8ceptibility of the charity'3 financial slalern8nls t# mat•ri81 mi8st3lèmÉnt, including obtaining an understanding of how fraud might occur. We #180 addre88ed the risk of fraud through management bias and overrlde of controls by., - updallng and reviewing our knowledge of the charity, Its Iru8lee8 ¥nd intèrnal fin8nclBI luncllon, lttghèr with Ih8lr systems and inlemal controls. This included maklng onqulrles of management as to Ihelr knoWdg of aclual. suspected and 8lleg8d fraud.. and ¢on8ldering the inlemal controls in place lo mlll9?lo ri$k$ of Iraud and non-compliance with laws gnd regulations.we concluded that whllst the charity had eontrols in pl8c8 that werè approprlata to its siz& and the nature of tts acUvitie&, wè could not rely on those 8y3lerns and internal ¢onlrols oxcluswely for the purposes of our audit work. We therefore adopted a 8ub8tantive and transactional approach lo our audit, Seeking lo verlfy figures In the balance sheet lo Ihifé party evidence and tran3019 wllhln the Slalemenl of Finan81 Acllvilies lo external independent documentation., W8 did not r8view 8V8ry transactlon, However, we adopted an 8ppro8¢h b86ed on testing a Sample of Ir8ns8Ctlons. In chooslng our samplo, wo le$ted transactions Ihat were material In nature and in addition a random sample of othgr Iransacllon. By ¢hoo$lng transactions ol a material nature, our audit work18 de8igned lo detect rnaleri81 mi$8lalaments. The use of random testing on other Iransadons Is designed to delecl other irregularitiès and the operallon of tho charlly'8 internal control systems generally. If exception5 were noted, our 8udll wort was expanded lo lesl mre tr8n$a¢llons wllh a view to d8t6rmlnlng whether the exception was of an i501aled nature.. We porfomied analyllcal pro¢edure8 to identify any unusual or unexpected relationships., We tested journal entries lo identify unusual transactions and investigated the rationale behlnd slgnlficanl or unu$u81 transactions. There are inherent limilallons In our audll procedures described above. The rnore removed that laws and regulations are from financial Iransaclions, the less Ilkely il Is that we would become BwBre of non-compliance. Auditing standard5 also limit the audit procedure3 re4uir¢d lo identify non-¢ornplionce with laws and regulations to enquiry of the Irustees and other m8naoemenl and the in8pection of r8gulatory and leg81 corrèspondenc8, if any. Molerlal mlsstsl¥monls Ihal orlse due lo fraud can be harder lo detect than those that arise from error as they may involve d¢liberal8 concealment or collusion. A further dèscripllon of our responslbS1rties for the audit of the financial slalements is located on the Financial R¢portin9 Councll's webslte at www.Irc.org.ukJaudrfLorsresponsibililies. This description forms part of our R8PQrt c)f th& Indep8ndenl Auditors. 31
Report of the Independent Audttors to the Trn$tee$ of Pain Relief Foundation Use of our report This report Is made solely lo tho ¢harStable companys Iru61ee8, as a body. in accordance with Part 4 of the Charities (Accounts and Repgrtsl Regulations 2008. Our audit work has been undèrtaken so that we might slate lo the charitabl8 company's trustees those Tn8tter8 we are ieqtjired to stale to them in an audilors, report and for no other purpose. Tts tha fullest extent permitt6d by law, w8 do not aceopt or assume responsibility to anyone olher than the ¢haritab1e company and ihe charitable MpanY'S trustees as a body, for our audrt work. for thls report, OT lor the oplnions we have formed. BTMR Llmlled Slatutory Auditor Eligible to act as an auditor In lem$ of Sectlon 1212 of the Companiès Aet 2006 Century Bulldings 14 St Mary's P8rson8gè Manchester M3 2DF 32
PAIN RELIEF FOUNDATION Statement of Flnancial Actlvitles for the Year Ended 5 April 2026 5.4.28 Total funds 5.4.25 Total funds Unr&striet8d funds Re$lricled fijnd Notes INCOME AND ENDOWMENTS FROM Donallcfis and legacies 137,483 137.484 116.590 Other trading activit188 Investrnenl in¢om& 29,984 103,706 61,798 91.782 103 706 45,186 Total 271 173 332.972 EXPENDITURE ON Ralslng tund$ Other trading acliville8 Investrnonl man8gernenl co¥18 17,603 17,603 18,084 29,270 29,270 29,858 Charltable actlvlt5es Research Education 419,319 27,796 447,115 336.798 5,441 Total 452 847 480 643 372 097 Nel g8in3 on Investments 261,405 261,405 45,638 NET INCOMEflEXPENDITUREI 79,731 34,003 113.734 180,2251 RECONCILIATION OF FUNDS Tolal lunds brought loNard 2.709,772 2,843 2.712.416 2,792,640 TOTAL FUNDS CARRIED FORWARD 2 789 S03 2 826,149 2712415 The notes form part of these finan¢i81 statements 33
PAIN RELIEF FOUNDATION Balance Shè•t S April 2026 5.4.26 Totsl funds 5.4.25 Total funds Unrestricted funds Restricted fund Notes FIXED ASSETS Tangible assets Investments 14 15 40,264 2 764.143 380 40,644 2,764,143 47,553 2,647,838 2.804,407 380 2.804,787 2.695.391 CURRENT ASSETS Stocks Deblors Cash at bank and in hand 16 631 1,756 35.082 631 1,756 653 2.27S 37,469 40,266 77,735 60,515 CREDITORS Amounts falling due within one year 18 152,3731 14.0001 156.3731 143,4911 NET CURRENT ASSETS 149041 21,382 17,024 TOTAL ASSETS LESS CURRENT LIABILITIES 2,789,503 36,646 2,826,149 2,712.415 NET ASSETS 2 789,S03 2 828 149 2 712415 FUNDS Unreslrlcted funds: General fund Designated unre8lrlcled 16641 2 790 067 35.142 2 674 630 2 789 503 2 709 772 Reslrlcled funds.. R¢strieted fund TOTAL FUNDS 2 826 149 2 712,415 These financial slalements have been 8uLliled under the requiremants of Section 145 of the Charllle$ Act 2011. The finBncSal slalement5 were approved by the Board of Trustees and authorlsed for Issue on.. and were slgned on its behalf by.. Chairman- Trustee The notes form part of these finan041 ¥latements 34
PAIN RELIEF FOUNDAMON Cash Flow Statgment fortFiè Year Ended 5 April 2026 5.4.26 5.4.25 Nol&s Cash flows from operating actlvltle Cash g8neraled from operations Finance costs paid Tax paid 1231,2781 1226} 460 1230,8311 12971 472 Net cash used in operating activikneB 231.0441 231.6001 Cash flows fram Inve6tlng actly1e8 Purchase of tangible fixed assets Purchase of fixed asset inve3trnenl¥ Sale of fLxed 81sè1 invèstmènts Interest ro¢eived Dividends r¢¢elved {1,9631 161.2891 228,382 1269,1121 414,212 103 898 N$1 cash provided by inv•stlng actlvlti8s 248 806 249 088 Chang• In ¢a$h and Cash •qulval•nts In the reporting pgrlod C¥8h and cash equlvalents at the bvginnlng of the reporting period 17,762 17.988 Cash and eA•h equlvalonts at the end of the reportlng perfod The notes form part ofthese financAal stalements 35
PAIN RELIEF FOUNDATION Notes to the Cash Flow Statement for the Year Ended S April 2026 RECONCILIATION OF NET INCOMEIIEXPENDITUREI TO NET CASH FLOW FROM OPERATING ACTIVITIES 6.4.26 5.4.25 Net lrt¢omell•xpèndltLtrl lor th r•portlng p•rlod las per the Statement L)f Flnanclal Actlvltie51 Adjustments for- Depreciation chargès Gain on investments Interest received Finance ¢9518 Dividend8 received Decrease in stocks Decrea$ellin¢reasel In debtors Increas¢1ld¢Giea8el In Gredltors 113,734 (80,2251 8.909 1261,4051 8,123 145,6381 1101 297 184,448) 226 {103,69BI 22 60 12.8B2 28,828 Net ca$h u$•d in op?Yali¢n$ 231 2781 30,8311 ANALYSIS OF CHANGES IN NET FUNDS At 6.4.25 Cash fflow At 5.4.26 N•t ca8h Cash al bank and In hand Total The notes form part of these financial statements 3e
PAIN RELIEF FOUNDATION Notes to the Flnanclal Statements for the Year Ended 5 April 2026 DESIGNATED FUND The designated fund repro$ènls ÈLJMS set asidé. o(rt of unr8Strict8d funds. to meet the ongoin9 Costs of the chair of Professor of Pain, 2026 2025 Investment income.. Interest receNtd Dividends Realised galns on Investments sold Unr88lised g8ln on revaluing investm&nts to marf(el value Total designated inGome Less.. Realised loss on sale of investments Unrealised profiV{lossl on revaluing inve51menls to nlathet value 5.665 98,033 154,488 4,036 60,412 71,207 258,186 155,655 106,917 111,6661 125,5691 111,7941 Expenditure out of designated funds Transfer of nel expenditure to General Fund OOD Net designat?d (exndItuT$)lln¢Om• IIIS,4371 1103,7081 ACCOUNTING POLICIES Bag18 of preparlng tho finan¢lal $tatem*nts The financial slalemenls of the ch3rily, which Is a publlc benefit enllly under FRS102, hav& be?n ppared in accordance with the Charill88 SORP IFRS 1021 'Accounllng and Rèportlng by Charillas,. Statement of Recommended Practic# appllcabl& lo charllles proparSng their accounts In a¢¢ordance wllh the Financial Reporting Standard applicable In the UK and Republic ol Iland IFRS 1021 leffe¢llve 1 Jonuary 20191,, and the Charitles Act 2011, The financlal 8talernen18 havo bg&n preparèd undèr th¥ hlslo(1¢81 cost convanlion with thè exception of Investments which are Included al rnarkel value. Income All income is recognised in the Slalemenl of Flnan¢lal Aclivltles once th& charity hos onlill&menl to the fund$ and 51 is probable that the incom8 will be received and the amount can b? measured reliably. Th8 charlly'3 incomé 1$ made up of gSfts. donatlon8, legacles, fundraislng, spon8or8hip and Investment Income. Expendlture Llabilities are recogni8ed as expenditure as Boon aB Ih¢ro 1$ a legal orconBlruclNe obllg?lion committing the charfly to that expenditure, it is probable that a Iransler of ècontsmlc benèfits will bÈ rèquired in sèttlèmènt and the amount of the obligation can be mea$ured reliably. Exp$ndllur¢ Is a¢¢ounl¥d for on an a¢cruals ba$ls and has been cla$8ifiod und¢r headings Ihol aggrggal¢ all costs related lo the category. Where costs cannot be directly attributed lo particular hgadings they h8v8 boèn allocated to Activitiès on a bagis consistant with the use of rèsources. Grants offered $ublecl lo ¢ondltlon$, such a$ duration of the grant, whlGh have nol been met al the year end date are noted as a commitment but not accrued a5 expenditure. Allocatlon and apportlonment of costs Certain expenditure is diredly attributable to SFAcific tIVitIeS and ha8 been included in Ih08e c08t categorie$. Certain olhercosls, which are alliibutable to more than ong aclivily, are apportionèd acrtsss categories on thé basls of an estimate of the proportion of lime spent by staff on those aclivilies. Tanglblè flxed ass•ts Depie¢iatlgn Is provlded at the following annual rates in order lo write off each asset over its estimated useful life. Long leasehold Plant and machinery Over the period of the lease 25°/ll on reducing balance and 150/ts on Cost Fixtures and ffittings 25Yll on cost Expenditure on indNidual assets which is les5 than £500 is not caw'talised. 37 continued...
PAIN RELIEF FOUNDATION Notes to the Financlal StateTnents-continued for the Year Ended 5 April 2026 ACCOUNTING POLICIES- contlnued Stocks Stocks art valued at th¢ lower of ¢osl artd nel reallsable value. after maklng due allowance for obsolete and slow moving ileffl8. TAxation The ch8ri1y is exempl from corporalSon lax on Ils charflable acllvllles. Fund accountlng UnreStrted funds can be used in accordance wilh the charitable obj8clive8 Èt thè distrÈtion ef tha tnjstees. Restriet&d funds can only b@ used for particular restricted purposes within thè obje¢ts of thè ¢harily. Re$trl¢llons arf$e when spe¢Med by Ihe donor or when funds are raised for particular reslrlcled purposes. De$lgnated fund The Designated fund represents the investment and i¢1o18d Incomè whSch th8 truslees have designated lo be used spe¢ifLcally far funding th8 ehsir of thè Piof&s8or of Pain. Rostrl¢ted fund Thè Restrict8d fund represents the income which was made availablè for the purposes of acquirfng a Transcranial Magnetic Scanner and sponsorships received. The related expendlluw ropre5enl monèy spent in relation to re$trS¢t¢d Income. Penslon cost8 and other pogt.retlrement beneflts Thè charity operalèB a defined contribution pen81on $chem8. Conlflbutlons payable to the charily'8 pension Scheme are charged lo the Statement ol Finart¢lal Acllvlties in the perfod to which they relate. Flnanclal Instruments Finan¢i81 instruments are c18sslfflod and accounted for aOrdIng to the substance of the contractual arrangem8nl. as gilhgr finan¢io18¥3g1¥, ffinanclal liabilities or èqulty Inslruments. An equlty in8lrumenl is any contract that evlden¢e8 8 resSdu¥l interest in th8 a88els of the Chority after deductlnq all ot ils Ildbilitle8. Investmonts Inv$¥tmonl$ ar9 madg by the trustaes Bdlng through and on advice of professional Inve8lmenl managers. The Investment 8lrategy focu3es on low lo mÈdlum rlsk inv8Stmenl5. Investment 9oln$ and IM$e• Gains and Ios5e8 whiGh aris? on the 8018 of invastmenis during th& year are termed "Realised galns and losses" Those gains and 105ses that 8riso from U)è disclosure of inveslments at market value as at 5th Aprll each ygar are lerrnèd'unreallsed galns and losses GovernAnee costs Govèm3nc• eosls rèlate to th8 gen8ral runnSng of the charity, as opposed lo fundr81$lng or ¢harltable aclivilie6 oxpenditure. They Include aud and legal fees. accountancy and related support costs. Costs of gonerating funds The costs of fundraising event5 include the ¢osls Incurred by lh& Chatlty in aangIng golf days, appèals 8nd sponsorships and are included in the SOFA on an accruals bas15. Charltable activltles- Grant5 payable Expenditure on charitable activities includes grants payable lo individu81s lo conduct reseorch Into paln. its cause8 and relief. and to disseminate research information logetherwilh related dir¢¢t ¢o$ts and support costs, all of which are accounted lor on an accruals basis. 38 continuèd...
PAIN RELIEF FOUNDATION Notes to the Financial Statements - ¢on¥nu8d for the Y•ar Ended S April 2026 DONATIONS AND LEGACIES &4.26 5.4.25 Gifts Gift alded donalons rax recoveiEd on glft aided donations Legacies Sundry income 38,912 3,111 14601 95,886 35 65,259 4,951 1,245 44,938 197 116.590 OTHER TRADING ACTIVITIES 5.4.26 5.4.25 Fundr8ising events Sponsorships Mgeting fees Le$ Codavef 4,297 7,225 18,462 1,205 5,535 26,440 91,782 INVESTMENT INCOME 5.4.26 5.4.25 LS3led Investments Dep¢sit &¢ceunt Inlere$t 103,698 84,448 103706 OTHER TRADING ACTIVITIES 5.4.26 5.4.25 Staff cwts INVESTMENT MANAGEMENT COSTS S.Q26 5.4.25 Portfollo management 11,667 CHARITABLE ACTIVITIES COSTS Grant fvnding of Support costs Ise8 note 101 Direct C081s (sèÈ notè 91 Tot813 Research Educatlon 107,825 58 273,690 6S,600 447.115 107.883 273 690 39 conlinued...
PAIN RELIEF FOUNDATION Notès to the Financial Statements- contlnued for the Year Ended 5 Apill 2026 GRANTS PAYABLE 5.4.26 5.4.25 Research 273,690 184,381 10. SUPPORT COSTS Information technology Governance cos18 Management Flnance Totals Reseorch Education 29,209 115 5,376 30,900 65,600 115 5,376 11. NET INCOMEIIEXPENDITUREI Nel Incornellexpendllurel13 8tsted after chargingllcr8dillngl.. 5.4.26 5.4.25 Audlloys, remunerallon Audllor$' remuneratlon for non audll work Depredatlon- owned assets 5,000 3,340 5,ODO 3.340 12. TRUSTEES, REMUNERATION AND BENEFITS No tru$loes' rgmuneralion or othgr beneffits were paid for the year ended 6 Aprfl 202S nor for Ihe yearended S Aprfl 2025. Tru$t•¢S' gxpgn$o• There were no Iru8tees' expen8e8 pald k)r the year ended 5 Apfil 2026 nor for the year ended S Aprll 2025. 13. STAFF COSTS The aver8ge numb$r of &mployees for the year wa$ 412024.. 41. 14. TANGIBLE FIXED ASSETS Flxlures and fitting8 Long leasehold Plant and machinery Tot81¥ COST At 6 April 2025 and 5 April 2026 114 302 204 403 326 983 64S 688 DEPRECIATION At 6 April 2025 Charge for year 81.319 3,266 192,604 2,950 324,212 693 598.135 Al 5 Aprtl 2026 195,554 324 905 605 044 NET BOOK VALUE At 5 April 2026 29,717 8,849 2,078 40,644 At S April 2025 32,983 11,799 2.771 40 continued..
PAIN RELIEF FOUNDATION Notes to the Financial Statements . ¢ontlnued for thè Y•ar Ended S April 2026 15. FIXED ASSET INVESTMENTS Listed investments MARKET VALue At 6 ApTiI 2025 Additions 01 ¢osl Disposals at book cost Revalualiong 2,647,838 269,112 12S9,7241 106 917 At 5 Aprll 2028 2 764.143 NET BOOK VALUE At S April 2026 2,764,143 At 5 Aprll 2025 2,647,838 OversBa8 investment a68ets amounted lo £674,62512025'. £731,204). Cosl gr valuation al S Aprll 202618 repr88entod by.. Llstsd Inv*stThènt• Valuation In 202$ Valuation In 2026 Cost 125,6691 106,917 2 682 796 2 764 143 16, STOCKS 5,4.26 5 4.25 Finished good$ 631 853 17. DEBTORS.. AMOUNTS FALLING DUE WITHIN ONEYEAR 5,4.26 5.4.25 Tax Prepaymenls and awwed In¢ome 778 97B 1,238 1.756 2,276 41 )ntInd...
PAIN RELIEF FOUNDATION Notes to th• Finan¢lal Statements - contlnued for the Year Ended S April 2026 18. CREDITORS.. AMOUNTS FALLING DUE WITHIN ONE YEAR 5.4.26 5.4.25 Accrua15 and deferred income 43,491 19. MOVENENT IN FUNDS Nel Transfers behveen fund5 movemant in funds Al 5.4.28 At 6.4.25 Unrestrictèd fund8 Genèral fund Design8ted unrèstdcted 35,142 2 674 630 1273,7061 3S3.437 238,000 238,0001 15641 2 790 067 2.709,772 79,731 2.789,503 Restricted fund8 Reslricled fund 2,643 34,003 38,646 TOTAL FUNDS 271241S 113734 2 826 149 Nel movemonl In funds, Included In the above are 0$ follow8.. Incoming resource Resources èxpended Ga1ns and losses Movement in funds UnreBtrfcted fund$ General fvnd Designated unra8lricted 167,474 103 899 1441,1801 11 6671 1273,7061 353 437 261 405 271,173 1452,8471 281,405 79,731 ReBtrlcted fund• Re8lrScled fund 61,799 127,7981 34,003 TOTAL FUNDS 332 972 480 6431 261405 113734 Comparatlv•g for movem•nt In funds Net movement in funds Transfers b¢¢wean funds Al 5.4.25 Al 6.4.24 Unrestrlcted funds 2,790,162 180,390) 2.709,772 Restrictgd fund Reslricled ILJnd 2,478 165 2,643 TOTAL FUNDS 2,792.e40 80,2251 2,712,415 42 continued...
PAIN RELIEF FOUNDATION Notes to the Flnancial Statements - continuod for thè Year Ended S April 2026 19. MOVEMENT IN FUNDS- contlnued ComparatNe nel movement in funds Included In Ihe above are as follows.. Incotning r8souiee$ Re5ourc¢s expèndèd Gains and Ioss8S Oven1 in funds Urtrestrlcted funds 234.228 1360,2561 45,638 180,3901 Reytrlcted fund Restricted fund 12,008 {11,841} 165 TOTAL FUNDS 24e.234 372,0971 45.e38 80.2251 A current year 12 months and prlor year 12 months comblned pogillon 1$ 0$ fc41ow8'. Nel movement In fund$ Transfers betr4een funds At 5.4.28 At8.4.24 Unr88tricted fund¥ 2,790.162 16S91 2,789.503 Restrlcted fund R*8lrl¢t8d fund 2,478 34.168 38,648 TOTAL FUNDS 2 792 640 2 826 149 Net movgrnenl In funils Included In the above aro 05 follows.. Incomlng resources Rosources expended Galn8 and lo$$es Moverronl In funds Unreslrl¢l?d funds 505,401 1813,103} 307,043 18591 Ro8trlcted fund Restricted fund 73,805 {39,6371 34,168 TOTAL FUNDS 852 7401 33 509 20. RELATED PARTY DISCLOSURES Th8r8 w8r• no r&l8tèd p8rty transactlons for the year ended S Aprll 2028. 21. FINANCIAL COMMITMENTS During the year grants payable lo researchers were approved in the total amount of £791,415 of which £564,407 remains payable in respect of fuEure periods. 43
PAIN RELIEF FOUNDATION Detailed Statemènt of Financial A¢tlvltSos for the Year Endgd 5 April 2026 5.4.26 5.4.25 INCOME AND ENDOWMENTS Donations and19ga¢le¥ Glfts Gilt aided don81ions Tax recovered on glft alded donatlon8 Legacies Sundry income 38.912 3,111 14601 95,886 35 65.259 4.951 1.245 44,938 197 137.484 116.590 Other trading activiti•$ Fundraising events Sponsorships Meeting fees Leeds Cadaver 4,297 7,225 18,462 61.798 1,205 5,535 26,440 12.006 91.782 46,186 Investment Ineom• Listed invÈ8tmÈnls Deposit occount Inlern8t 103,698 84,448 10 103,708 TolaS Incomlng r•$our¢s$ 332,972 246.234 EXPENDITURE Othgr tradlng Actlyltltrs Waggs Social sacurily P&n$lon¥ 17,128 254 221 17,272 585 207 17,603 18.064 Investment management co¥ts Portfollo management 11.667 11.794 Charltable a¢VI Wages Social security Pensions V8nu& & meeung costs Sundry Leeds Cadaver DoproGialion of tangibl& ffixgd assets Grants lo indlviduals 54,068 1,118 2,207 15,488 424 27,669 6,909 273,690 55,351 1,986 2.083 11,812 285 10,198 8.123 184,381 381,sn 274,199 Support costs Management Rates and water Carried forward 18,836 18,836 18.427 18,427 This page does not form part of the stafvtory financial statements
PAIN RELIEF FOUNDATION Detailod Statèment of Financial Actlvltles for the Year End¢d S April 2026 5.4.26 5.4_25 Management BroughtfoWl Insurance Telephone Postagè and st8tion8ry Advertising Sundries Computer soflware Credit card chBrges 18,836 3,756 380 2,917 4,548 918 1,82a 226 18,427 3,546 753 2,308 4,442 1,457 1,765 297 33,409 32,9 Flnance Bank charges 115 192 Infomiation t&¢hnology Repalr5 and ienewals 5,376 5,214 Gov•man¢o cost8 Wage$ social security Pen8lDns Auditor$' remunerallon Auditors, ramuner81ion for non audit work 21,207 472 881 5,000 19,850 612 837 5.000 3,340 Total r¢8our¢&$ expended 480 643 372 097 Ngt •xpenditure bof¢ro g•ln$ #nd lo$$¥$ 1147,6711 (125,8831 Roall8•d rg¢ognls•d g8ln8 and lo•s Not inv#8lmènl gainsl Iltsssesl 154488 Nèt In¢om?11gxpendltur?I 54,658 This pagè doès not form part of the statutory finan¢ial statements 45
Paln Ralief Foundation